484 results on '"Di Pilla, A."'
Search Results
2. Sleep habits and sleep disorders in Italian children and adolescents: a cross-sectional survey.
- Author
-
Breda, Maria, Belli, Arianna, Esposito, Dario, Di Pilla, Andrea, Melegari, Maria, Malorgio, Emanuela, Doria, Mattia, Ferri, Raffaele, Bruni, Oliviero, and DelRosso, Lourdes
- Subjects
adolescents ,children ,infant ,preschoolers ,sleep disorders ,sleep habits ,Female ,Humans ,Adolescent ,Male ,Cross-Sectional Studies ,Retrospective Studies ,Sleep ,Sleep Wake Disorders ,Sleep Initiation and Maintenance Disorders ,Italy ,Surveys and Questionnaires ,Habits - Abstract
STUDY OBJECTIVES: The aim was to describe sleep habits and epidemiology of the most common sleep disorders in Italian children and adolescents. METHODS: This was a cross-sectional study in which parents of typically developing children and adolescents (1-18 years) completed an online survey available in Italy, gathering retrospective information focusing on sleep habits and disorders. RESULTS: Respondents were 4,321 typically developing individuals (48.6% females). Most of our sample did not meet the age-specific National Sleep Foundation recommendations for total sleep duration (31.9% of toddlers, 71.5% of preschoolers, 61.6% of school-age children, and 41.3% of adolescents). Napping was described in 92.6% of toddlers and in 35.2% of preschoolers. Regarding geographical differences, children and adolescents of northern Italy showed more frequent earlier bedtimes and rise times than their peers of central and southern Italy. The most frequently reported sleep disorder in our sample was restless sleep (35.6%), followed by difficulties falling asleep (16.8%), > 2 night awakenings (9.9%), and bruxism (9.6%). Data also suggest that longer screen time is associated with later bedtimes on weekdays in all age groups. CONCLUSIONS: The current study shows that Italian children are at risk of sleep disorders, particularly insufficient sleep, restless sleep, and difficulty falling asleep. The study also provides normative sleep data by age group in a large cohort of typically developing Italian children, emphasizing the importance of the developmentally, ecologically, and culturally based evaluation of sleep habits and disorders. CITATION: Breda M, Belli A, Esposito D, et al. Sleep habits and sleep disorders in Italian children and adolescents: a cross-sectional survey. J Clin Sleep Med. 2023;19(4):659-672.
- Published
- 2023
3. Leiomyosarcoma of the inferior vena cava
- Author
-
Maria Antonietta Di Pilla, Marco Alex Capuano, Mariangela Rossi, Gianni Di Pilla, Rocco Minelli, Paolo Pizzicato, Antonio Rossi, Giuseppe Paviglianiti, Donatella Irace, Gianfranco Vallone, Antonio A.H. Salvia, Maria Cristina Smaldone, Valentina Cariello, Raffaele Zeccolini, and Eugenio Rossi
- Subjects
Leiomyosarcoma ,Inferior vena cava ,Retroperitoneal masses ,Integrated imaging ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Inferior vena cava leiomyosarcoma is a rare malignant mesenchymal tumor that originates from the smooth muscle cells of the venous media and is more frequent in females in the V-VI decade of life. Due to scarce and specific symptoms, diagnosis is not simple, and often metastases to the liver, lungs, and/or lymph nodes are already present. A 44-year-old male patient arrives at our institution presenting diffuse abdominal pain and a sense of weight associated with lumbar pain. He showed nothing relevant except for a moderate consumption of alcohol. Ultrasound examination of the abdomen revealed liver enlargement with hyperechoic nodularity and clear margins. Furthermore, the presence of a voluminous solid nodular formation was found, with an inhomogeneous echostructure and moderate vascularization on Doppler. Inferior vena cava leiomyosarcoma is a rare malignancy. The diagnosis is usually established after surgery, however, recurrences are common and the role of chemoradiation therapy remains to be defined. The only potential treatment is surgical resection with possible vessel reconstruction and en bloc removal of adjacent structures with 5 and 10-year survival rates of 49% and 29%, respectively.
- Published
- 2024
- Full Text
- View/download PDF
4. Liposarcoma of the spermatic cord: The state of art and our experience
- Author
-
Maria Antonietta Di Pilla, Marco Alex Capuano, Mariangela Rossi, Gianni Di Pilla, Rocco Minelli, Paolo Pizzicato, Antonio Rossi, Giuseppe Paviglianiti, Donatella Irace, Gianfranco Vallone, Antonio A.H. Salvia, Maria Cristina Smaldone, Valentina Cariello, Raffaele Zeccolini, and Eugenio Rossi
- Subjects
Liposarcoma ,Spermatic cord ,Scrotal masses ,Integrated imaging ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Liposarcoma of the spermatic cord is a malignant neoformation so rare that less than 200 cases are reported in the world. It is a tumor that originates from adipose tissue and when it is found in the spermatic cord it can deceptively simulate an inguinal hernia and not be easily identified. The present work describes the case of a 37-year-old man with liposarcoma of the spermatic cord who arrives at our institution with painless swelling of the left testicle. Physical examination revealed a painless swelling in the scrotal sac. The scrotal ultrasound examination revealed a mass, measuring 8 cm (cranio-caudal) × 5.4 cm (latero-lateral) × 8 cm (antero-posterior) and characterized later with a basal CT examination of the abdomen. The patient was subsequently surgically treated with excision of the tumor, plus hernial plastic with plug and mesh. Histological examination revealed a mature adipocyte neoplasm whose morphological and molecular characteristics (amplification of the MDM2 gene) are consistent with the diagnosis of dediferrentiated liposarcoma variety CO-MINGLED, G2 (sec. FNCLCC). The patient is currently under cancer surveillance with no signs of loco-regional recurrence. Spermatic cord liposarcoma is an extremely rare malignancy. It's not easy to identify as it can simulate an inguinal hernia, hydrocele, lipoma, funicular cyst, or testicular tumor. Diagnosis is usually established postsurgery, however, relapses are common and the role of chemo-radiotherapy remains to be defined.
- Published
- 2023
- Full Text
- View/download PDF
5. A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study)
- Author
-
A. Di Pilla, C. Nero, M. L. Specchia, F. Ciccarone, L. Boldrini, J. Lenkowicz, B. Alberghetti, A. Fagotti, A. C. Testa, V. Valentini, E. Sala, and G. Scambia
- Subjects
Medicine ,Science - Abstract
Abstract Current approach to identify BRCA 1/2 carriers in the general population is ineffective as most of the carriers remain undiagnosed. Radiomics is an emerging tool for large scale quantitative analysis of features from standard diagnostic imaging and has been applied also to identify gene mutational status. The objective of this study was to evaluate the clinical and economic impact of integrating a radiogenomics model with clinical and family history data in identifying BRCA mutation carriers in the general population. This cost-effective analysis compares three different approaches to women selection for BRCA testing: established clinical criteria/family history (model 1); established clinical criteria/family history and the currently available radiogenomic model (49% sensitivity and 87% specificity) based on ultrasound images (model 2); same approach used in model 2 but simulating an improvement of the performances of the radiogenomic model (80% sensitivity and 95% specificity) (model 3). All models were trained with literature data. Direct costs were calculated according to the rates currently used in Italy. The analysis was performed simulating different scenarios on the generation of 18-year-old girls in Italy (274,000 people). The main outcome was to identify the most effective model comparing the number of years of BRCA-cancer healthy life expectancy (HLYs). An incremental cost-effectiveness ratio (ICER) was also derived to determine the cost in order to increase BRCA carriers-healthy life span by 1 year. Compared to model 1, model 2 increases the detection rate of BRCA carriers by 41.8%, reduces the rate of BRCA-related cancers by 23.7%, generating over a 62-year observation period a cost increase by 2.51 €/Year/Person. Moreover, model 3 further increases BRCA carriers detection (+ 68.3%) and decrease in BRCA-related cancers (− 38.4%) is observed compared to model 1. Model 3 increases costs by 0.7 €/Year/Person. After one generation, the estimated ICER in the general population amounts to about 3800€ and 653€ in model 2 and model 3 respectively. Model 2 has a massive effect after only one generation in detecting carriers in the general population with only a small cost increment. The clinical impact is limited mainly due to the current low acceptance rate of risk-reducing surgeries. Further multicentric studies are required before implementing the integrated clinical-radiogenomic model in clinical practice.
- Published
- 2024
- Full Text
- View/download PDF
6. Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
- Author
-
Quattrone, Martina, Di Pilla, Alessia, Pagano, Livio, and Fianchi, Luana
- Published
- 2023
- Full Text
- View/download PDF
7. Giussani e i Padri della Chiesa: Una tradizione vivente
- Author
-
Mattia Antonio Agostinone, Pierluigi Banna, Gianmario Cattaneo, Giuliano Chiapparini, Alessandra Di Pilla, Leonardo Lugaresi, Sincero Mantelli, Giulio Maspero, Angela Maria Mazzanti, Alberto Nigra, Ilaria Vigorelli, Andrea Zauli, Pierluigi Banna
- Published
- 2024
8. The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19
- Author
-
Accornero, Stefano, Aghemo, Alessio, Ali, Hussam, Angelini, Claudio, Arcari, Ivan, Arosio, Paola, Azzolini, Elena, Baccarin, Alessandra, Badalamenti, Salvatore, Baggio, Sara, Barbagallo, Michela, Barberi, Caterina, Barbic, Franca, Barbieri, Viviana, Barbone, Alessandro, Basciu, Alessio, Bocciolone, Monica, Borea, Federica, Borroni, Mario, Bresciani, Gianluigi, Brunetta, Enrico, Bulletti, Cinzia, Cadonati, Cristina, Calabro', Lorenzo, Calatroni, Marta, Calvetta Albania, Antonietta, Cannata, Francesco, Canziani, Lorenzo, Capretti Giovanni, Luigi, Carlani, Elisa, Carrone, Flaminia, Casana, Maddalena, Cecconi, Maurizio, Ceriotti, Carlo, Ciccarelli, Michele, Cimino, Matteo, Ciuffini, Leonardo, Colaizzi, Chiara, Colapietro, Francesca, Costa, Guido, Cozzi, Ottavia, Craviotto, Vincenzo, Crespi, Chiara, Crippa, Massimo, Da Rio, Leonardo, Dal Farra, Sara, D'Antonio, Federica, De Ambroggi, Guido, De Donato, Massimo, De Lucia, Francesca, De Santis, Maria, Delle Rose, Giacomo, Di Pilla, Marina, Dipaola, Franca, Dipasquale, Andrea, Dipasquale, Angelo, Droandi, Ginevra, Fazio, Roberta, Ferrante, Giuseppe, Ferrara Elisa, Chiara, Ferrari Matteo, Carlo, Ferri, Sebastian, Folci, Marco, Foresti, Sara, Franchi, Eloisa, Fraolini, Elia, Fugazza, Alessandro, Furfaro, Federica, Galimberti, Paola, Galtieri Alessia, Piera, Gavazzi, Francesca, Generali, Elena, Goletti, Benedetta, Guidelli, Giacomo, Jacobs, Flavia, Kurihara, Hayato, Lagioia, Michele, Libre', Luca, Lleo, Ana, Loiacono, Ferdinando, Lughezzani, Giovanni, Maccallini, Marta, Maiorino Alfonso, Francesco, Malesci, Alberto, Mantovani, Riccardo, Marchettini, Davide, Marinello, Arianna, Markopoulos, Nikolaos, Masetti, Chiara, Milani, Angelo, Mirani, Marco, Morelli, Paola, Motta, Francesca, Mundula, Valeria, Nigro, Mattia, Omodei, Paolo, Ormas, Monica, Pagliaro, Arianna, Paliotti, Roberta, Parigi Tommaso, Lorenzo, Pedale, Rosa, Pegoraro, Francesco, Pellegatta, Gaia, Pellegrino, Marta, Petriello, Gennaro, Piccini, Sara, Pocaterra, Daria, Poliani, Laura, Preatoni, Paoletta, Procopio, Fabio, Puggioni, Francesca, Pugliese, Luca, Racca, Francesca, Randazzo, Michele, Regazzoli Lancini, Damiano, Reggiani, Francesco, Rodolfi, Stefano, Ruongo, Lidia, Sacco, Clara, Sandri Maria, Teresa, Savi, Marzia, Scarfo', Iside, Shiffer, Dana, Sicoli, Federico, Solano, Simone, Solitano, Virginia, Stainer, Anna, Stella Matteo, Carlo, Strangio, Giuseppe, Taormina, Antonio, Testoni, Lucia, Tordato, Federica, Trabucco, Angela, Ulian, Luisa, Valentino, Rossella, Valeriano, Chiara, Vena, Walter, Verlingieri, Simona, Vespa, Edoardo, Voza, Antonio, Zanuso, Valentina, Zilli, Alessandra, Anfray, Clement, Belgiovine, Cristina, Bertocchi, Alice, Bombace, Sara, Brescia, Paola, Calcaterra, Francesca, Calvi, Michela, Cancellara, Assunta, Capucetti, Arianna, Carenza, Claudia, Carloni, Sara, Carnevale, Silvia, Cazzetta, Valentina, Coianiz, Nicolò, Darwich, Abbass, Davoudian, Sadaf, De Paoli, Federica, Di Donato, Rachele, Digifico, Elisabeth, Durante, Barbara, Farina Floriana, Maria, Ferrari, Valentina, Fornasa, Giulia, Franzese, Sara, Ghasemi, Somayehsadat, Gil Gomez, Antonio, Giugliano, Silvia, Gomes Ana, Rita, Lizier, Michela, Lo Cascio, Antonino, Melacarne, Alessia, Mozzarelli, Alessandro, My, Ilaria, Oresta, Bianca, Pasqualini, Fabio, Pastò, Anna, Pelamatti, Erica, Perucchini, Chiara, Pozzi, Chiara, Rimoldi, Valeria, Rimoldi, Monica, Scarpa, Alice, Scavello, Francesco, Silvestri, Alessandra, Sironi, Marina, Spadoni, Ilaria, Spano', Salvatore, Spata, Gianmarco, Supino, Domenico, Tentorio, Paolo, Ummarino, Aldo, Valentino, Sonia, Zaghi, Elisa, Zanon, Veronica, Mapelli, Sarah N., Nappi, Emanuele, García Martín, Ian David, Leone, Roberto, Angelotti, Giovanni, Zhong, Hang, Magrini, Elena, Stravalaci, Matteo, Protti, Alessandro, Santini, Alessandro, Costantini, Elena, Savevski, Victor, Bottazzi, Barbara, Bartoletti, Michele, Mantovani, Alberto, and Garlanda, Cecilia
- Published
- 2024
- Full Text
- View/download PDF
9. Stroke pathway performance assessment: a retrospective observational study
- Author
-
Jacopo Camporesi, Silvia Strumia, Andrea Di Pilla, Matteo Paolucci, Diego Orsini, Chiara Assorgi, Maria Gabriella Cacciuttolo, and Maria Lucia Specchia
- Subjects
Stroke pathway ,Pharmacological thrombolysis ,COVID-19 ,Performance assessment ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background and Aim Performance assessment of the Stroke Pathway is a key element in healthcare quality. The aim of this study has been to carry out a retrospective assessment of the Stroke Pathway in a first level Stroke Unit in Italy, analyzing the temporal trend of the Stroke Pathway performance and the impact of the COVID-19 pandemic. Methods A retrospective observational study was carried out analyzing data from 1/01/2010 to 31/12/2020. The following parameters were considered: volume and characteristics of patients with ischemic stroke undergoing intravenous thrombolysis, baseline modified Rankin Scale (mRS) and National Institutes of Health Stroke Scale (NIHSS) scores, Onset-to-Door (OTD), Door-To-Imaging (DTI) and Door-To-Needle (DTN) Times, mRS score 3 months after the ischemic event onset (3 m-mRS) and NIHSS score 24 h after the ischemic event onset (24 h-NIHSS). The study also compared the pre-COVID-19 pandemic period (March-December 2019) with the one immediately following it (March-December 2020). Results 418 patients were included. Over time, treatment was extended to older patients (mean age from 66.3 to 75.51 years; p = 0.006) and with a higher level of baseline disability (baseline mRS score from 0.22 to 1.22; p = 0.000). A statistically significant reduction over the years was found for DTN, going from 90 min to 61 min (p = 0.000) with also an increase in the number of thrombolysis performed within the “golden hour” – more than 50% in 2019 and more of 60% in 2020. Comparing pre- and during COVID-19 pandemic periods, the number of patients remained almost unchanged, but with a significantly higher baseline disability (mRS = 1.18 vs. 0.72, p = 0.048). The pre-hospital process indicator OTD increased from 88.13 to 118.48 min, although without a statistically significant difference (p = 0.197). Despite the difficulties for hospitals due to pandemic, the hospital process indicators DTI and DTN remained substantially unchanged, as well as the clinical outcome indicators 3 m-mRS, NHISS and 24 h-NHISS. Conclusions The results of the retrospective assessment of the Stroke Pathway highlighted its positive impact both on hospital processes and patients’ outcomes, even during the COVID-19 pandemic, so that the current performance is aligning itself with international goals. Moreover, the analysis showed the need of improvement actions for both hospital and pre-hospital phases. The Stroke Pathway should be improved with the thrombolysis starting in the diagnostic imaging department in order to further reduce the DTN score. Moreover, health education initiatives involving all the stakeholders should be promoted, also by using social media, to increase population awareness on timely recognition of stroke signs and symptoms and emergence medical services usage.
- Published
- 2023
- Full Text
- View/download PDF
10. Positive Energy Districts: Fundamentals, Assessment Methodologies, Modeling and Research Gaps
- Author
-
Anna Kozlowska, Francesco Guarino, Rosaria Volpe, Adriano Bisello, Andrea Gabaldòn, Abolfazl Rezaei, Vicky Albert-Seifried, Beril Alpagut, Han Vandevyvere, Francesco Reda, Giovanni Tumminia, Saeed Ranjbar, Roberta Rincione, Salvatore Cellura, Ursula Eicker, Shokufeh Zamini, Sergio Diaz de Garayo Balsategui, Matthias Haase, and Lorenza Di Pilla
- Subjects
positive energy districts ,world café method ,stakeholder engagement ,PED design ,PED implementation ,Technology - Abstract
The definition, characterization and implementation of Positive Energy Districts is crucial in the path towards urban decarbonization and energy transition. However, several issues still must be addressed: the need for a clear and comprehensive definition, and the settlement of a consistent design approach for Positive Energy Districts. As emerged throughout the workshop held during the fourth edition of Smart and Sustainable Planning for Cities and Regions Conference (SSPCR 2022) in Bolzano (Italy), further critical points are also linked to the planning, modeling and assessment steps, besides sustainability aspects and stakeholders’ involvement. The “World Café” methodology adopted during the workshop allowed for simple—but also effective and flexible—group discussions focused on the detection of key PED characteristics, such as morphologic, socio-economic, demographic, technological, quality-of-life and feasibility factors. Four main work groups were defined in order to allow them to share, compare and discuss around five main PED-related topics: energy efficiency, energy flexibility, e-mobility, soft mobility, and low-carbon generation. Indeed, to properly deal with PED challenges and crucial aspects, it is necessary to combine and balance these technologies with enabler factors like financing instruments, social innovation and involvement, innovative governance and far-sighted policies. This paper proposes, in a structured form, the main outcomes of the co-creation approach developed during the workshop. The importance of implementing a holistic approach was highlighted: it requires a systematic and consistent integration of economic, environmental and social aspects directly connected to an interdisciplinary cross-sectorial collaboration between researchers, policymakers, industries, municipalities, and citizens. Furthermore, it was reaffirmed that, to make informed and reasoned decisions throughout an effective PED design and planning process, social, ecological, and cultural factors (besides merely technical aspects) play a crucial role. Thanks to the valuable insights and recommendations gathered from the workshop participants, a conscious awareness of key issues in PED design and implementation emerged, and the fundamental role of stakeholders in the PED development path was confirmed.
- Published
- 2024
- Full Text
- View/download PDF
11. Microbial Biocontrol Agents and Natural Products Act as Salt Stress Mitigators in Lactuca sativa L.
- Author
-
Claudio Caprari, Antonio Bucci, Anastasia C. Ciotola, Carmine Del Grosso, Ida Dell’Edera, Sabrina Di Bartolomeo, Danilo Di Pilla, Fabio Divino, Paola Fortini, Pamela Monaco, Davide Palmieri, Michele Petraroia, Luca Quaranta, Giuseppe Lima, and Giancarlo Ranalli
- Subjects
abiotic stress ,biocontrol ,stress mitigation ,antagonistic microorganism ,plant biostimulation ,Lactuca sativa var. romana ,Botany ,QK1-989 - Abstract
One of the major problems related to climate change is the increase in land area affected by higher salt concentrations and desertification. Finding economically and environmentally friendly sustainable solutions that effectively mitigate salt stress damage to plants is of great importance. In our work, some natural products and microbial biocontrol agents were evaluated for their long-term effectiveness in reducing salt stress in lettuce (Lactuca sativa L. var. romana) plants. Fourteen different treatments applied to soil pots, with and without salt stress, were analyzed using biometric (leaf and root length and width), physiological (chlorophyll and proline content), and morphological (microscopic preparations) techniques and NGS to study the microbial communities in the soil of plants subjected to different treatments. Under our long-term experimental conditions (90 days), the results showed that salt stress negatively affected plant growth. The statistical analysis showed a high variability in the responses of the different biostimulant treatments. Notably, the biocontrol agents Papiliotrema terrestris (strain PT22AV), Bacillus amyloliquefaciens (strain B07), and Rahnella aquatilis (strain 36) can act as salt stress mitigators in L. sativa. These findings suggest that both microbial biocontrol agents and certain natural products hold promise for reducing the adverse effects of salt stress on plants.
- Published
- 2024
- Full Text
- View/download PDF
12. An online survey among general pediatricians on melatonin use in children with chronic insomnia
- Author
-
Bruni, Oliviero, Breda, Maria, Malorgio, Emanuela, Brambilla, Paolo, Ceschin, Flavia, Di Pilla, Andrea, Elia, Maurizio, and Ferri, Raffaele
- Published
- 2024
- Full Text
- View/download PDF
13. Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
- Author
-
Emiliano Giardina, Paola Mandich, Roberta Ghidoni, Nicola Ticozzi, Giacomina Rossi, Chiara Fenoglio, Francesco Danilo Tiziano, Federica Esposito, Sabina Capellari, Benedetta Nacmias, Rossana Mineri, Rosa Campopiano, Luana Di Pilla, Federica Sammarone, Stefania Zampatti, Cristina Peconi, Flavio De Angelis, Ilaria Palmieri, Caterina Galandra, Eleonora Nicodemo, Paola Origone, Fabio Gotta, Clarissa Ponti, Roland Nicsanu, Luisa Benussi, Silvia Peverelli, Antonia Ratti, Martina Ricci, Giuseppe Di Fede, Stefania Magri, Maria Serpente, Serena Lattante, Teuta Domi, Paola Carrera, Elisa Saltimbanco, Silvia Bagnoli, Assunta Ingannato, Alberto Albanese, Fabrizio Tagliavini, Raffaele Lodi, Carlo Caltagirone, Stefano Gambardella, Enza Maria Valente, and Vincenzo Silani
- Subjects
C9orf72 ,GGGGCC hexanucleotide repeat ,amyotrophic lateral sclerosis ,frontotemporal dementia ,allele distribution ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
IntroductionHigh repeat expansion (HRE) alleles in C9orf72 have been linked to both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); ranges for intermediate allelic expansions have not been defined yet, and clinical interpretation of molecular data lacks a defined genotype–phenotype association. In this study, we provide results from a large multicenter epidemiological study reporting the distribution of C9orf72 repeats in healthy elderly from the Italian population.MethodsA total of 967 samples were collected from neurologically evaluated healthy individuals over 70 years of age in the 13 institutes participating in the RIN (IRCCS Network of Neuroscience and Neurorehabilitation) based in Italy. All samples were genotyped using the AmplideXPCR/CE C9orf72 Kit (Asuragen, Inc.), using standardized protocols that have been validated through blind proficiency testing.ResultsAll samples carried hexanucleotide G4C2 expansion alleles in the normal range. All samples were characterized by alleles with less than 25 repeats. In particular, 93.7% of samples showed a number of repeats ≤10, 99.9% ≤20 repeats, and 100% ≤25 repeats.ConclusionThis study describes the distribution of hexanucleotide G4C2 expansion alleles in an Italian healthy population, providing a definition of alleles associated with the neurological healthy phenotype. Moreover, this study provides an effective model of federation between institutes, highlighting the importance of sharing genomic data and standardizing analysis techniques, promoting translational research. Data derived from the study may improve genetic counseling and future studies on ALS/FTD.
- Published
- 2024
- Full Text
- View/download PDF
14. Stroke pathway performance assessment: a retrospective observational study
- Author
-
Camporesi, Jacopo, Strumia, Silvia, Di Pilla, Andrea, Paolucci, Matteo, Orsini, Diego, Assorgi, Chiara, Cacciuttolo, Maria Gabriella, and Specchia, Maria Lucia
- Published
- 2023
- Full Text
- View/download PDF
15. A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study
- Author
-
Di Pilla, Andrea, Nero, Camilla, Specchia, Maria Lucia, Ciccarone, Francesca, Boldrini, Luca, Lenkowicz, Jacopo, Alberghetti, B, Fagotti, Anna, Testa, Antonia Carla, Valentini, Vincenzo, Sala, Evi, Scambia, Giovanni, Di Pilla A, Nero C, Specchia ML (ORCID:0000-0002-3859-4591), Ciccarone F, Boldrini L, Lenkowicz J, Fagotti A (ORCID:0000-0001-5579-335X), Testa AC (ORCID:0000-0003-2217-8726), Valentini V (ORCID:0000-0003-4637-6487), Sala E, Scambia G (ORCID:0000-0003-2758-1063), Di Pilla, Andrea, Nero, Camilla, Specchia, Maria Lucia, Ciccarone, Francesca, Boldrini, Luca, Lenkowicz, Jacopo, Alberghetti, B, Fagotti, Anna, Testa, Antonia Carla, Valentini, Vincenzo, Sala, Evi, Scambia, Giovanni, Di Pilla A, Nero C, Specchia ML (ORCID:0000-0002-3859-4591), Ciccarone F, Boldrini L, Lenkowicz J, Fagotti A (ORCID:0000-0001-5579-335X), Testa AC (ORCID:0000-0003-2217-8726), Valentini V (ORCID:0000-0003-4637-6487), Sala E, and Scambia G (ORCID:0000-0003-2758-1063)
- Abstract
Current approach to identify BRCA 1/2 carriers in the general population is ineffective as most of the carriers remain undiagnosed. Radiomics is an emerging tool for large scale quantitative analysis of features from standard diagnostic imaging and has been applied also to identify gene mutational status. The objective of this study was to evaluate the clinical and economic impact of integrating a radiogenomics model with clinical and family history data in identifying BRCA mutation carriers in the general population. This cost‐effective analysis compares three different approaches to women selection for BRCA testing: established clinical criteria/family history (model 1); established clinical criteria/family history and the currently available radiogenomic model (49% sensitivity and 87% specificity) based on ultrasound images (model 2); same approach used in model 2 but simulating an improvement of the performances of the radiogenomic model (80% sensitivity and 95% specificity) (model 3). All models were trained with literature data. Direct costs were calculated according to the rates currently used in Italy. The analysis was performed simulating different scenarios on the generation of 18‐year‐old girls in Italy (274,000 people). The main outcome was to identify the most effective model comparing the number of years of BRCA‐cancer healthy life expectancy (HLYs). An incremental cost‐effectiveness ratio (ICER) was also derived to determine the cost in order to increase BRCA carriers‐healthy life span by 1 year. Compared to model 1, model 2 increases the detection rate of BRCA carriers by 41.8%, reduces the rate of BRCA‐related cancers by 23.7%, generating over a 62‐year observation period a cost increase by 2.51 €/Year/Person. Moreover, model 3 further increases BRCA carriers detection (+ 68.3%) and decrease in BRCA‐related cancers (− 38.4%) is observed compared to model 1. Model 3 increases costs by 0.7 €/Year/Person. After one generation, the estimated ICER in the
- Published
- 2024
16. DELTA - Distributed Elastic Log Text Analyser.
- Author
-
Pierluigi Di Pilla, Remo Pareschi, Francesco Salzano, and Federico Zappone
- Published
- 2022
17. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
- Author
-
Pan, Hongchao, Peto, Richard, Henao Restrepo, Ana Maria, Preziosi, Marie-Pierre, Sathiyamoorthy, Vasee, Karim, Quarraisha Abdool, Alejandria, Marissa, Hernàndez García, César, Kieny, Marie-Paule, Malekzadeh, Reza, Murthy, Srinivas, Reddy, K. Srinath, Periago, Mirta Roses, Hanna, Pierre Abi, Abutidze, Akaki, Ader, Florence, Al-Bader, Abdullah, Alhasawi, Almonther, Allum, Emma, Al Mawali, Adhra, Alotaibi, Athari, Alvarez- Moreno, Carlos, Appadoo, Sheila, Arts, Derk, Asiri, Abdullah, Aukrust, Pål, Barratt-Due, Andreas, Genetu Bayih, Abebe, Beaumont, Helena, Bellani, Samir, Benassi, Virginia, Bhargava, Balram, Branca, Mattia, Cappel-Porter, Heike, Cerrato, Nery, Cheick Haidara, Fadima, Chow, Ting Soo, Como, Nadia, Eustace, Joe, Gabunia, Tamar, García, Patricia, Godbole, Sheela, Gotuzzo, Eduardo, Griskevicius, Laimonas, Hamra, Rasha, Hassan, Mariam, Hassany, Mohamed, Hutton, David, Irmansyah, Irmansyah, Jancoriene, Ligita, Khamis, Faryal, Kirwan, Jana, Kumar, Suresh, Lennon, Peter, Lopardo, Gustavo, Lydon, Patrick, Magrini, Nicola, Manevska, Suzana, Manuel, Oriol, McGinty, Sybil, Medina, Marco, Mesa Rubio, Maria Lucia, Miranda Montoya, Maria Consuelo, Nel, Jeremy, Nunes, Estevao, Perola, Markus, Portoles, Antonio, Rasmin, Menaldi, Raza, Aun, Rees, Helen, Reges, Paula, Rogers, Chris, Salami, Kolawole, Salvadori, Marina, Sauermann, Mamatha, Sinani, Narvina, Sow, Samba, Sterne, Jonathan AC, Stevanovikj, Milena, Tacconelli, Evelina, Tavares Maltez, Fernando Manuel, Teferi, Mekonnen, Tikkinen, Kari, Trelle, Sven, Tsertsvadze, Tengiz, Zaid, Hala, Røttingen, John-Arne, Swaminathan, Soumya, Ryan, Michael, Gjermeni, Nevila, Meta, Esmeralda, Aguila, Damian, Alonso, Ignacio, Altamirano, Marcos, Alvarez, María, Alzola, Rodrigo, Arce, Veronica, Arribillaga, Patricia, Avila, Rafael, Balbuena, Juan, Barcelona, Laura, Barletta, José, Benedetti, María, Berdiñas, Verónica, Burgui, Julieta, Caimi, Sabrina, Carrillo, Juan, Carrizo, Juan, Castelli, Juan, Cazaux, Alexis, Cervellino, Flavia, Chalco, Angelo, Chediack, Viviana, Cunto, Eleonora, D'Amico, Nicolàs, de Vedia, Lautaro, Delgado, Carolina, Di Pilla, Debora, Díaz, Miguel, Díaz Aguiar, Pablo, Domínguez, Cecilia, Ellero, Leonor, Farina, Javier, Fernàndez, José, Ferreyra, Roxana, Filippi, María, Fogar, Carolina, Frare, Pablo, Giudiche, Celeste, Golikow, Mariana, Gomez, Maria Georgina, Hermida, Laura, Hurtado, Mariano, Jacobo, Mariela, Jaume, Martin, Laplume, Diego, Lescano, María, Lista, Nicolàs, Loiacono, Flavia, López, Ana Belen, Losso, Marcelo, Luna, Cecilia, Lupo, Sergio, Marianelli, Leonardo, Martin, Anabella, Masciottra, Florencia, Mykietiuk, Analía, Orellano, Lorena, Pachioli, Valeria, Padilla, María José, Pallavicini, Cecilia, Patroso, Jazmin, Perez Blanco, Luz, Presas, Jose Louis, Provenzano, Matias, Lavera, Lorena, Reichert, Viviana, Riveros, Florencia, Rodríguez, Alejandra, Rolon, María José, Salvay, Carolina, Simonetta, María, Sisto, Alicia, Themines, Sandra, Tito, Fernando, Toibaro, Javier, Torales, Graciela, Verón, Luciano, Vizzotti, Carla, Egle, Alexander, Greil, Richard, Joannidis, Michael, Altdorfer, Antoine, Belkhir, Leila, Fraipont, Vincent, Hites, Maya, Arruda, Erico, Breda, Giovanni, Colussi, Arthur, Corradi, Miran, Croda, Julio, Duani, Helena, João, Esaú, Machado, Elizabeth, Mello, Fernanda, Miranda Filho, Demócrito, Monteiro, Poliana, Nunes, Ceuci, Pereira Junior, Luiz Carlos, Pinto, Gustavo, Raboni, Sonia, Ramos, Marcelo, Ruffing, Leonardo, Santos, Valdilea, Souza, Tamara, Medeiros, Melissa, Schwarzbold, Alexandre, Ali, Karim, Azher, Tanweer, Bellemare, David, Binnie, Alexandra, Borgia, Sergio, Cavayas, Yiorgos Alexandros, Chagnon, Nicholas, Cheng, Matthew, Cloutier, Eve, Conly, John, Costiniuk, Cecilia, Daneman, Nick, Douglas, James, Downey, Catarina, Duan, Erick, Durand, Medeline, English, Shane, Farjou, George, Fera, Evadiki, Fontela, Patricia, Fowler, Rob, Fralick, Mike, Gamble, David Gregory, Geagea, Anna, Grant, Jennifer, Harrison, Luke, Havey, Thomas, Hoang, Holly, Kelly, Lauren, Keynan, Yoav, Khwaja, Kosar, Klein, Marina, Kolan, Christophe, Kronfli, Nadine, Lamontagne, Francois, Lee, Nelson, Lee, Todd, Lim, Rachel, Lostun, Alexandra, MacIntyre, Erika, Malhamé, Isabelle, Martin-Carrier, Francois, McGuinty, Marlee, Munan, Matthew, O'Neil, Conar, Ovakim, Daniel, Papenburg, Jesse, Parhar, Ken, Parvathy, SeemaNair, Perez-Patrigeon, Santiago, Rishu, Asgar, Rushton, Moira, Scherr, Kim, Schwartz, Kevin, Semret, Makeda, Silverman, Micahel, Singh, Ameeta, Sligl, Wendy, Smith, Stephanie, Somayaji, Ranjani, Tan, Darrell, Tran, Tuong-Vi, Tremblay, Alain, Tsang, Jennifer, Turgeon, Alexis, Vakil, Erik, Weatherald, Jason, Yansouni, Cedric, Zarychanski, Ryan, Aristizabal, Claudia, Bravo, Juan, Caicedo, Monica, Chacón, Julio, Garzón, Diego, Guevara, Fredy, Lozano-Gonzàlez, Silvia, Macareno, Hugo, Montañez-Ayala, Anita, Oñate, Jose, Rojas-Gambasica, Jose, Rosso, Fernando, Saavedra, Carlos, Valderrama, Sandra, Vàquiro-Herrera, Eliana, Varón-Vega, Fabio, Zuluaga, Ivan, Abdel Baki, Amin, Abdelbary, Akram, Abdel-Razek, Wael, Amin, Wagdi, Asem, Noha, Elassal, Gehan, Elshesheny, Marwa, Fathy, Mohamed, Fathy, Naglaa, Fayed, Notaila, Hammam, Ahmed, Hassany, Sahar, Ibrahim, Hamdy, Kamal, Ehab, Masoud, Hossam, Mohamed, Maryam, Mohamed Gouda, Abdullah, Moustafa, Ehab, Okasha, Shaimaa, Rafik, Ahmed, Said, Ahmed, Sedky, Asmaa, Solyman Kabil, Mohamed, Tarek, Sara, Tharwat, Ahmed, Zaky, Samy, Abegaz, Emawayish Tesema, Bekele, Zelalem Mekonnen, Asfaw, Filmona Mekuria, Tegegne, Netsanet Aragaw, Teklemariam, Miheret Fikre, Nigusse, Frehiwot Tamiru, Achalu, Daniel Legesse, Weldegergs, Shewit Tesfagabr, Huluka, Dawit Kebede, Tereda, Addisu Birhanu, Ala-Kokko, Tero, Delany, Jutta, Ekroos, Heikki, Hankkio, Riina, Haukipää, Mia, Hetemäki, Iivo, Holma, Pia, Holmberg, Ville, Horstia, Saana, Jalkanen, Ville, Jämsänen, Toni, Järventie, Juuso, Järvinen, Petrus, Kalliala, Ilkka, Kauma, Heikki, Kilpeläinen, Tuomas, Kreivi, Hanna-Riikka, Kuitunen, Ilari, Lamminmäki, Satu, Mäkinen, Laura, Mäntylä, Jarkko, Mattila, Tiina, Myllärniemi, Marjukka, Niskanen, Joni, Nykänen, Taina, Nyqvist, Miro, Paajanen, Juuso, Partanen, Terhi, Patovirta, Riitta-Liisa, Paukkeri, Erja-Leena, Puusti, Emmi, Renner, Andreas, Reponen, Emma, Risku, Sari, Rosberg, Tuomas, Rutanen, Jarno, Säilä, Petrus, Salonen, Päivi, Sinisalo, Marjatta, Sivenius, Katariina, Tuominen, Susanna, Aboab, Jerone, Alfaiate, Toni, Andrejak, Claire, Andreu, Pascal, Belhadi, Drifa, Benezit, Francois, Botelho-Nevers, Elisabeth, Bouadma, Lila, Bougon, David, Bouiller, Kevin, Bounes, Fanny, Boyer, Alexandre, Bruel, Cédric, Buffet, Alexandre, Burdet, Charles, Cazanave, Charles, Chabertier, Cyrille, Clere-Jehl, Rapahel, Costagliola, Dominique, Courjon, Johan-Victor, Crockett, Flora, Danion, Francois, Dechanet, Aline, Dellamonica, Jean, Delmas, Christelle, Diallo, Alpha, Djossou, Felix, Dubost, Clement, Dupont, Axelle, Epaulard, Olivier, Faure, Emmmanuel, Faure, Karine, Fayol, Antoine, Figueiredo, Samy, Fougerou, Claire, Gaborit, Benjamin, Gaci, Rostane, Gagneux-Brunon, Amandine, Gallien, Sebastien, Garot, D, Goehringer, Francois, Gruson, Didier, Hinschberger, Olivier, Hulot, Jean-Sebastien, Jaureguiberry, Stephane, Jean-Michel, Vanessa, Kerneis, Solen, Kimmoun, Antoine, Klouche, Kada, Lachatre, Marie, Lacombe, Karine, Laine, Fabrice, Lanoix, Jean Philippe, Laribi, Samira, Launay, Odile, Laviolle, Bruno, Le Moing, Vincent, Le Pavec, Jerome, Lebeaux, David, Leroy, Sylvie, Lescure, Xavier, Livrozet, Marine, Makinson, Alain, Malvy, Denis, Marquette, Charles-Hugo, Martin-Blondel, Guillaume, Mayaux, Julien, Mekontso Dessap, Armand, Mentre, France, Mercier, Noemie, Meziani, Ferhat, Molina, Jean Michel, Mootien, Yoganaden, Mourvillier, Bruno, Navellou, Jean Christoph, Noret, M, Peiffer- Smadja, Nathan, Peytavin, Gilles, Pialoux, Gilles, Pilmis, Benoît, Piroth, Lionel, Poindron, Vincent, Poissy, Julien, Pourcher, Valerie, Quenot, Jean Pierre, Raffi, Francois, Reignier, Jean, Richard, Jean Christoph, Robert, Céline, Saillard, Juliette, Sayre, Naomi, Senneville, Eric, Stefan, Francois, Tellier, Marie Capucine, Terzi, Nicolas, Textoris, Julien, Thiery, Guillame, Timsit, Jean Francois, Tolsma, Violaine, Tubiana, Sarah, Wallet, Florent, Yazdanpanah, Yazdan, Zerbib, Yoann, Aguilar, Carlos, Erazo, Laura, Fiallos, Angel, Figueroa, Rosbinda, Flores, Juan Jose, Melendez, Lesddyy, Moncada, Wendy, Abraham, Ooriapadickal Cherian, Acharya, Chetankumar, Aedula, Vinaya Sekhar, Aggarwal, Richa, Agrawal, Nishant, Agrawal, Umang, Agrawal, Abhishekh, Ahmad, Mohammad, Atal, Shubham, Babu, Avinash, Baidya, Dalim Kumar, Balachandran, Amith, Bangar, Rakhee, Bhadade, Rakesh, Bhandari, Sudhir, Bhapal, Meghavi, Bhardwaj, Pankaj, Bhati, Gaurav, Bhatia, Pradeep, Bhatt, Krishnakant, Bingi, Thrilok Chander, Borse, Rohidas, Buch, Vyom, Chand, Dipti, Chandwani, Ashish, Charan, Jaykaran, Chaudhari, Mayur, Chaudhari, Kirti, Chaudhary, Vipul, Chauhan, Nishant, Chikara, Gaurav, Daswani, Bharti, de Souza, Rosemarie, Desai, Chetna, Divakar, Balusamy, Divhare, Sujeet, Dorairajan, Suresh Kumar, Dutt, Naveen, Ethirajan, Therani Rajan, Gamit, Amit, Gamit, Sweta, Garg, Mahendra, Goenka, Ajay, Goenka, Aniket, Guleria, Randeep, Gupta, Paras, Gupta, Nivedita, Gupta, Madhur, Harde, Minal, Ingle, Vaibhav, Iyer, Shivkumar, Jamalapuram, Vaishnavi, Jayanthi, Rangarajan, Joshi, Rajnish, Kadam, Abhijeet, Kalakuntla, Hemanth, Kalikar, Mrunalini, Kalme, Sayali, Kamble, Suchit, Kant, Ravi, Kantharia, Bansari, Kashikar, Arundhati, Kavishvar, Abhay, Kayina, Choro Athipro, Kerkar, Pranali, Khadanga, Sagar, Khandare, Sagar, Kokate, Pranjali, Komathi, Jayavelu, Krishnan, Vijay, Krishnan, Jayasree, Krishnan, Sumitra, Kulur Mukhyaprana, Sudha, Kumarasamy, N, Mahavar, Sunil, Maitra, Souvik, Majumdar, Falguni, Malhotra, Supriya, Mamulwar, Megha, Malini, Padma, Marwah, Vikas, Maurya, Akhilesh, Mehta, Kedar, Mesipogu, Rajarao, Misra, Shobha, Mitra, Sajal, Mittal, Ankit, Mohan, Bharathi, Momin, Mohmmedirfan, Nag, Vijaya, Nagarajan, Ramakrishnan, Nagmani, Kammili, Narlawar, Uday, Natarajan, Gopalakrishnan, Nischal, Neeraj, Ogale, Dhananjay, Palat, Paltial, Panda, Prasan, Panda, Samiran, Pandya, Amee, Parate, Rohit, Paritekar, Arunita, Patel, Parvati, Patel, Chetna, Patel, Sunaina, Patel, Vitan, Patel, Deep, Patel, Harshad, Patil, Girish, Peter, Deepu, Prasad, Durga, Purohit, Vimlesh, Rabindrarajan, Ebenezer, Ranganathan, Lakshmiarasimhan, Rao, Tushara, Rao, Chakradhara, Rathod, Chirag, Raval, Devang, Ray, Avik, Reddy, Kamini, Rege, Sujata, Revathi, Ayyasamy, Roy, Dhara, Saigal, Saurabh, Sane, Suvarna, Sangale, Shashi, Seetharaman, Krishnamoorthy, Selvamuthu, Poongulali, Seshaiah, Kurada Venkata, Shadrach, Benhur, Shah, Jignesh, Shah, Sonal, Sharma, Swati, Sharma, Raman, Sharma, Shrikant, Singh, Krishna, Singh, Anil, Singh, Arjeet, Singhai, Abhishek, Soneja, Manish, Soni, Kapil Dev, Subhan, Thasneem banu, Subramaniam, Sudharshini, Sudarsanam, Thambu David, Sudarsi, Ravindra Kumar, Suleman, Dawood, Suthar, Nilay, Talati, Shriraj, Tambe, Murlidhar, Tejomurtula, Tilak, Tirupakuzhi Vijayaraghavan, Bharatkumar, Trikha, Anjan, Trivedi, Aarti, Udwadia, Zarir, Upadhyay, Kamlesh, Vasava, Ashwin, Vasudevan, Damodaran, Velayudham, Rajendran, Venkatasubramanian, Ramasubramanian, Verma, Mamta, Waghmare, Rakesh, Waikar, Anushka, Wig, Naveet, Afrilia, Annisa Rizky, Amin, Muhammad, Arlinda, Dona, Avrina, Rossa, Bang, Lois, Djaharuddin, Irawaty, Djojo, Aryan, Driyah, Sri Laning, Erastuti, Mila, Fajarwati, Tetra, Harsini, Harsini, Hartantri, Yovita, Herman, Deddy, Isbaniah, Fathiyah, Karyana, Muhammad, Kusuma, Indra, Mahmudji, Harli Amir, Medison, Irvan, Nugroho, Agung, Nurhayati, Nurhayati, Opitasari, Cicih, Pitoyo, Ceva Wicaksono, Pradana, Antonius Arditya, Raharjo, Sofyan Budi, Rahmaini, Ade, Risniati, Yenni, Riyanto, Bambang Sigit, Sajinadiyasa, I Gede Ketut, Sari, Flora Eka, Sitompul, Pompini Agustina, Soedarsono, Soedarsono, Somia, I Ketut Agus, Sugiri, Yani Jane, Sugiyono, Retna Indah, Susanto, Nugroho Harry, Syarif, Armaji Kamaludi, Yulianto, Aris, Afsharian, Mandana, Akhavi Mirab, Atefehsadat, Amini, Fatemeh, Amini, Mahnaz, Ansarin, Khalil, Baba Mahmoodi, Farhang, Baghaei, Parvaneh, Barazandeh, Fateme, Bayani, Masomeh, Dastan, Farzaneh, Ebrahimpour, Soheil, Eghtesad, Sareh, Fallahi, Mohammad Javad, Fallahpoor Golmaee, Fatemeh, Foroghi Ghomi, Seyed Yaser, Ghadir, Mohammad Reza, Gheitani, Mina, Ghiasvand, Fereshteh, Hafizi Lotfabadi, Saied, Hakamifard, Atousa, Hashemi Madani, Shima Sadat, Hormati, Ahmad, Hosseini, Hamed, Janbakhsh, Alireza, Javanian, Mostafa, Joukar, Farahnaz, Kamali, Alireza, Karampour, Amin, Khajavirad, Nasim, Khodabakhshi, Behnaz, Khodadadi, Javad, Khodashahi, Rozita, Kiani Majd, Somaieh, Mahfoozi, Lida, Mahmoodiyeh, Behnam, Mansour-Ghanaei, Fariborz, Mansouri, Feizollah, Mesgarpour, Bita, Mesri, Mehdi, Mikaeili, Haleh, Miladi, Ronak, Moghadami, Mohsen, Mohamadi, Payam, Mohraz, Minoo, Mohseni Afshar, Zeinab, Moogahi, Sasan, Mousavi Anari, Seyed Alireza, Mozaffar, Seyyed Hassan, Mozdourian, Mahnaz, Najafipour, Reza, Najari, Hamidreza, Nazemiyeh, Masoud, Norouzi, Alireza, Pourkazemi, Aydin, Poustchi, Hossein, Saberhosseini, Seyedeh Naeimeh, Saberi, Marzieh, Saber-Moghaddam, Niloufar, Sadeghi, Anahita, Sadeghi Haddad Zavareh, Mahmoud, Sahraian, Mohammad Ali, Salahi, Mehrdad, Salehi, Mohammad Reza, Sarmadian, Hossein, Sayad, Babak, Shirani, Kiana, Shirvani, Maria, Shojaei, Daryanaz, Shokri, Mehran, Siami, Zeinab, Sima, Ali Reza, Soleimani, Alireza, Soltanmohammad, Saedeh, Tabarsi, Payam, Taghizadieh, Ali, Tavassoli, Samaneh, Varnasseri, Mehran, Vaziri, Siavash, Yadyad, Mohammad Jaafar, Yaghoubi, Shoeleh, Yazdanpanah, Yalda, Yousefi, Farid, Zamanian, Mohammad Hossein, Zand, Farid, Zare Hoseinzade, Elham, Bergin, Colm, Cotter, Aoife, de Barra, Eoghan, Jackson, Arthur, Laffey, John, McCarthy, Cormac, Muldoon, Eavan, Sadlier, Corinna, Maguire, Teresa, Angheben, Andrea, Bai, Francesca, Bandera, Alessandra, Barchiesi, Francesco, Bassetti, Matteo, Bisi, Luca, Bonfanti, Paolo, Calò, Federica, Campoli, Caterina, Canovari, Benedetta, Capetti, Amedeo, Castelli, Francesco, Cauda, Roberto, Cingolani, Antonella, Cocco, Nicolò, Coppola, Nicola, Corcione, Silvia, Cremonini, Eleonora, d'Arminio Monforte, Antonella, de Gaetano Donati, Katleen, De Nardo, Pasquale, De Rosa, Francesco Giuseppe, Degioanni, Maria, Della Siega, Paola, Di Bella, Stefano, Drera, Bruno, Focà, Emanuele, Fornabaio, Chiara, Galli, Massimo, Giacomazzi, Donatella, Gori, Andrea, Gustinetti, Giulia, Iannuzzi, Francesca, Kertusha, Blerta, Lamonica, Silvia, Lichtner, Miriam, Lupia, Tommaso, Luzzati, Roberto, Macera, Margherita, Menatti, Elisabetta, Merelli, Maria, Merlini, Esther, Monari, Caterina, Pan, Angelo, Pecori, Davide, Pezzani, Diletta, Riccardi, Niccolò, Rodari, Paola, Roldan, Eugenia, Rovere, Pierangelo, Rusconi, Stefano, Scabini, Silvia, Tascini, Carlo, Viale, Pierluigi, Vincenzi, Marcello, Zuccalà, Paola, Zucchi, Patrizia, Al-Roomi, Moudhi, Al-Sabah, Salman, Schrapp, Kelly, Hassoun, Mahmoud, Matar, Madonna, Dbouni, Oussaima, Yared, Nadine, Saliba, Michele, Farra, Anna, Riachi, Moussa, Zablockiene, Birute, Reuter, Jean, Staub, Therese, Ab Wahab, Suhaila, Chew, Chun Keat, Chua, Hock Hin, Goh, Pik Pin, Lee, Heng Gee, Leong, Chee Loon, Low, Lee Lee, Mak, Wen Yao, Mohamed Gani, Yasmin, Muhamad, Dzawani, Zaidan, Nor Zaila, Ducker, Camilla, Demiri, Ilir, Aballi, Saad, Berg, Åse, Blomberg, Bjørn, Dalgard, Olav, Dyrhol-Riise, Anne Ma, Eiken, Ragnhild, Ernst, Gernot, Hannula, Ranula, Haugli, Metter, Heggelund, Lars, Hoel, Hedda, Hoff, Dag Arne Lihaug, Holten, Aleksander Rygh, Johannessen, Asgeir, Kåsine, Trine, Kildal, Anders Benjamin, Kittang, Bård Reikvam, Nezvalova-Henriksen, Katerina, Olsen, Inge Christoffer, Olsen, Roy Bjørkolt, Skei, Nina Vibeche, Skudal, Hilde, Tholin, Birgitte, Thoresen, Lars, Trøseid, Marius, Tveita, Anders, Vinge, Leif, Ystrøm, Carl Magnus, Al Jahdhami, Issa, AlNaamani, Khalid, Al Balushi, Zakariya, Pandak, Nenad, Abbas, Salma, Akhtar, Nasim, Azam, Sumeyya, Begum, Dilshad, Hassan, Sadia, Herekar, Fivzia, Khan, Shahzaib, Khan, Ejaz Ahmed, Mahmood, Syed Faisal, Nasir, Nosheen, Rahim, Anum, Sarfaraz, Samreen, Shaikh, Qurat-ul-Ain, Sultan, Faisal, Walayat, Usman, Agurto-Lescano, Erika Cecilia, Alcantara-Díaz, Andrés Martín, Alva-Correa, Ana María, Alvarado-Moreno, José Gustavo, Ángeles-Padilla, Bethsabé, Arbañil-Huamàn, Hugo César, Ávila-Reyes, Pool Christopher, Azañero-Haro, Johan Alexander, Barreto-Rocchetti, Luis Guillermo, Benitez-Peche, Jorge Marko A., Bernal-Màlaga, Karla Hortencia, Cabrera-Portillo, Liliana Norma, Carazas-Chavarry, Reynaldo Javier, Càrcamo, Paloma Mariana, Casimiro-Porras, Indira Catalina, Castillo-Espinoza, Jhuliana, Chacaltana-Huarcaya, Jesús Norberto, Cornejo-Valdivia, Carla Raquel, Cruz-Chereque, Augusto, Del-Aguila-Torres, Keith Cayetano Marcelino, Díaz-Chipana, Erika, Flores-Valdez, Neil, Franco-Vàsquez, Rosanna Andrea, Gallegos-López, Roxana Consuelo, Gastiaburú-Rodriguez, Dauma Yesenia, Gianella-Malca, Gonzalo Ernesto, Gomero-Lopez, Andrés Alonso, Hercilla-Vàsquez, Luis Enrique, Hueda-Zavaleta, Miguel Ángel, Ibarcena-Llerena, Claudia Vanessa, Iberico-Barrera, Carlos Alberto, Inquilla-Castillo, Miguel Angel, Juàrez-Eyzaguirre, Jesus Alberto, Laca-Barrera, Manuel, León-Jiménez, Franco, Luna-Wilson, Carla Vanessa, Màlaga, German, Marin, Ricardo, Mejía-Cordero, Fernando, Mendoza-Laredo, Juan Arturo, Meregildo-Rodríguez, Edinson Dante, Miranda-Manrique, Gonzalo Francisco, Olivera-Chaupis, Marco, Ortega-Monasterios, Fatima Josefina, Otazú-Ybàñez, Jimmy Pedro, Paredes-Moreno, María Angélica, Peña-Mayorga, Claudia Ximena, Peña-Vàsquez, Olivia del Carmen, Peña-Villalobos, Alejandro, Ponce, Oscar J, Ponte-Fernandez, Katherin Estefania, Pro, Jose, Quispe-Nolazco, César Miguel, Ramos-Samanez, Manuel Efrain, Rojas-Murrugarra, Kory Mirtha, Samanez-Pérez, Jorge Mauro, Sànchez-Carrillo, Halbert Chrostian, Sànchez-Garavito, Epifanio, Sànchez-Sevillano, Ricardo Manuel, Sandoval-Manrique, Hernan, Santos-Revilla, Gabriela, Silva-Ramos, Julio Antonio, Solano-Ico, Manuel Alberto, Soto, Alonso, Sotomayor-Woolcott, Giannilu Michelle, Tapia-Orihuela, Ruben Kevin Arnold, Terrazas-Obregón, Carmen Sara, Terrones-Levano, Victor Francisco, Ticona-Huaroto, Cesar Eduardo, Torres-Ninapayta, Walter, Torres-Ruiz, Oscar Martin, Ugarte-Mercado, Dario, Vargas-Anahua, Orlando José, Vàsquez-Becerra, Ruben Dario, Vàsquez-Cerro, José Gabriel, Villegas-Chiroque, Miguel, Williams, Anna Larson, Yauri-Lazo, Randi Mauricio, Abad, Cybele Lara, Andales-Bacolcol, Silverose Ann, Arcegono, Marlon, Arches, Jamie, Astudillo, Mary Grace, Aventura, Emily, Awing, Arlyn, Bala, Mishelle Vonnabie, Bello, Jia An, Blanco, Peter, Benedicto, Jubert, Buno, Susana, Cabrera, Justine, Cajulao, Thea Pamela, Caoili, Janice, Casiple-Amsua, Lina, Catambing, Victor, Chin, Inofel, Chua, Ma. Bernadette, Chua, Mitzi Marie, Climacosa, Fresthel Monica, David-Wang, Aileen, De los Reyes, Virginia, Europa, Gilly May, Fernandez, Lenora, Francisco, Jorge, Garcia, Gerard, Garcia, Jemelyn, Gler, Maria Tarcela, Isidro, Marie Grace Dawn, Javier, Rozelle Jade, Kwek, Marion, Lansang, Mary Ann, Lee, Aileen, Li, Kingbherly, Llanes, Mark Ramon Victor, Llorin, Ryan, Macadato, Omar Khayyam, Malundo, Anna Flor, Mercado, Maria Elizabeth, Mujeres, Mercedes, Nepomuceno, Marisse, Ngo-Sanchez, Katha, Orden, Mary Claire, Pablo-Villamor, Maria Philina, Paez, Ruel Dionisio, Palmes, Patricio, Panaligan, Marion, Quinivista-Yoon, Jenny Mae, Ramos, Mary Shiela Ariola, Ramos -Penalosa, Christine, Reyes, Sheila Marie, Roa, Kathryn, Roman, Arthur Dessi, Rosario, Minette Claire, Roxas, Evalyn, Santos, Lourdes Ella Gonzales, Soldevilla, Helmar, Solante, Rontgene, Suaco, Jane, Tagarda, Daisy, Tang, Issa Rufina, Te, Bob, Teo, Dennis, Tibayan, Christopher John, Villalobos, Ralph Elvi, Ymbong, Duane Richard, Zabat, Gelza Mae, Batkova, Stepanka, Cardoso, Orlando, Garrote, Ana-Raquel, Lino, Sara, Manata, Maria-José, Pinheiro, Helder, Póvoas, Diana, Ramirez, Freddy, Seixas, Diana, Naji, Assem, Al Gethamy, M Al, AL-Mulaify, Mohammed Sami, Al Maghraby, Reem, Alrajhi, A, Al Sharidi, Aynaa, Alotaibi, Naif, AlShaharani, F, Barry, Mazin, Ghonem, Leen, Khalel, Anas, Kharaba, Ayman Mohammed, Alabdan, Lulwah, AlAbdullah, Mohammed Sharaf, Al Shabib, Abdullah, Bengu, Simangele, Bennet, Jacklyn, Dubula, Thozama, Howell, Pauline, Janse van Vuuren, Cloete, Kalla, Ismail, Lifson, Aimee, Maasdorp, Shaun, Magua, Nombulelo, Maluleke, Vongani, Mbhele, Nokuphiwa, Mdladla, Nathi, Mendelson, Mark, Menezes, Colin, Mwelase, Thando, Nchabeleng, Maphoshane, Palanee-Phillips, Thesla, Parker, Victoria, Rassool, Mohammed, Reeder, Paul, Sossen, Bianca, Steyn, Dewald, Tsitsi, Merika, van Blydenstein, Sarah Alex, Venter, Michelle, Van Vuuren, Janse, Venturas, Jacquie, Abad Pérez, Daniel, Abenza, Maria José, Alarcón-Payer, Carolina, Armero Garrigos, Eva, Arribas, Jose Ramon, Ascaso, Ana, Berenguer, Juan, Cabello-Clotet, Noemí, Chamorro Tojeiro, Sandra, Cuenca-Acevedo, Rafael, de la Calle, Fernando, Del Toro, Maria Dolores, Díaz Pollàn, Beatriz, Diez, Cristina, Esquillor-Rodrigo, María José, Estrada, Vicente, Fanciulli, Chiara, Fanjul, Francisco, Fernàndez de Orueta, Lucía, Ferre, Adrian, Ferreira Pasos, Eva Maria, Gainzarain-Arana, Juan-Carlos, Garcia, Felipe, García Deltoro, Miguel, Goikoetxea Agirre, Ane Josune, Gómez Barquero, Julia, Gomez-Huelgas, Ricardo, Gonzàlez Moraleja, Julio, Guijarro, Carlos, Gutierrez, Felix, Guzmàn, Jesús, Ibarguren, Maialen, Iribarren, Jose Antonio, Jerusalem, Koen, Juan Arribas, Arturo, Lalueza, A, Leone, Antonio, Lopez Azkarreta, Iñigo, Lozano-Martin, Daniel, Lucendo, Alfredo J, Luengo López, Mariella, Martín Oterino, JA, Masa, JF, Merino, Esperanza, Monge-Maillo, Begoña, Moran-Rodríguez, Miguel-Angel, Muñez Rubio, Elena, Muñoz Sanchez, Josefa, Nuñez Orantos, Maria Jose, Nuño, Enrique, Ortiz-De-Zarate-Ibarra, Zuriñe, Pagàn-Muñoz, Bàrbara, Paño-Pardo, José Ramón, Peñaranda, Maria, Pérez Chica, Gerardo, Pérez Fernàndez, AM, Pérez-López, Carmen, Polo San Ricardo, Victor, Portu-Zapirain, Joseba, Puchades, Francesco, Rivas Paterna, Ana Belen, Rodríguez Vidigal, Francisco F, Rodríguez-Baño, Jesus, Ruiz-Seco, Pilar, Ryan, Pablo, Saez-De-Adana, Ester, Salas, Rosario, Salavert Lletí, Miguel, Sandoval, Raquel, Toyas-Miazza, Carla, Valencia, Jorge, Vargas, Emilio, Velasco, Maria, Von Wichmann, Miguel Angel, Bosshard, Andreas, Calmy, Alexandra, Castro, Tiago, Cavassini, Matthias, Clerc, Olivier, Conen, Anna, Desbaillets, Nicolas, Desgranges, Florian, Duss, Francois, Emonet, Stephane, Erard, Veronique, Eyer, Myriam, Fayet-Mello, Aurélie, Flammer, Yvonne, Friedl, Andrée, Fulchini, Rosamaria, Furrer, Hansjakob, Garin, Nicolas, Gastberger, Salome, Greiner, Michael, Haefliger, David, Haubitz, Sebastian, Hoffmann, Matthias, Isenring, Egon, Jakopp, Barbara, Lampert, Markus, Marinosci, Annalisa, Martin, Yvonne, Petignat, Pierre-Auguste, Piso, Rein Jan, Prendki, Virginie, Rutishauser, Jonas, Schaefer, Elisabeth, Schmiedel, Yvonne, Schwery, Stefan, Stavropoulou, Elisavet, Stoeckle, Marcel, Suttels, Veronique, Thurnher, Maria Christine, van den Bogaart, Lorena, West, Emily, Wiegand, Jan, and Wiggli, Benedikt
- Published
- 2022
- Full Text
- View/download PDF
18. Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study
- Author
-
Squizzato, Alessandro, Galliazzo, Silvia, Rancan, Elena, Di Pilla, Marina, Micucci, Giorgia, Podda, Gianmarco, Valeriani, Emanuele, Campiotti, Leonardo, Bertù, Lorenza, Ageno, Walter, Porreca, Ettore, and Lodigiani, Corrado
- Published
- 2022
- Full Text
- View/download PDF
19. Listening to what the system tells us: Innovative auditing for distributed systems
- Author
-
Piergiuseppe Di Pilla, Remo Pareschi, Francesco Salzano, and Federico Zappone
- Subjects
distributes systems ,log auditing ,log analysis ,NLP ,blockchain ,Hyperledger Fabric ,Electronic computers. Computer science ,QA75.5-76.95 - Abstract
IntroductionIn recent years, software ecosystems have become more complex with the proliferation of distributed systems such as blockchains and distributed ledgers. Effective management of these systems requires constant monitoring to identify any potential malfunctions, anomalies, vulnerabilities, or attacks. Traditional log auditing methods can effectively monitor the health of conventional systems. Yet, they run short of handling the higher levels of complexity of distributed systems. This study aims to propose an innovative architecture for system auditing that can effectively manage the complexity of distributed systems using advanced data analytics, natural language processing, and artificial intelligence.MethodsTo develop this architecture, we considered the unique characteristics of distributed systems and the various signals that may arise within them. We also felt the need for flexibility to capture these signals effectively. The resulting architecture utilizes advanced data analytics, natural language processing, and artificial intelligence to analyze and interpret the various signals emitted by the system.ResultsWe have implemented this architecture in the DELTA (Distributed Elastic Log Text Analyzer) auditing tool and applied it to the Hyperledger Fabric platform, a widely used implementation of private blockchains.DiscussionThe proposed architecture for system auditing can effectively handle the complexity of distributed systems, and the DELTA tool provides a practical implementation of this approach. Further research could explore this approach's potential applications and effectiveness in other distributed systems.
- Published
- 2023
- Full Text
- View/download PDF
20. Leiomyosarcoma of the inferior vena cava
- Author
-
Di Pilla, Maria Antonietta, primary, Capuano, Marco Alex, additional, Rossi, Mariangela, additional, Di Pilla, Gianni, additional, Minelli, Rocco, additional, Pizzicato, Paolo, additional, Rossi, Antonio, additional, Paviglianiti, Giuseppe, additional, Irace, Donatella, additional, Vallone, Gianfranco, additional, Salvia, Antonio A.H., additional, Smaldone, Maria Cristina, additional, Cariello, Valentina, additional, Zeccolini, Raffaele, additional, and Rossi, Eugenio, additional
- Published
- 2024
- Full Text
- View/download PDF
21. The value of surgical admissions for malignant uterine cancer. A comparative analysis of robotic, laparoscopic, and laparotomy surgery in a university hospital
- Author
-
Maria Lucia Specchia, Giovanni Arcuri, Andrea Di Pilla, Emanuele La Gatta, Tommaso Osti, Prospero Limongelli, Giovanni Scambia, and Rocco Domenico Alfonso Bellantone
- Subjects
value-based healthcare ,oncology ,public health ,healthcare system ,robotic ,Public aspects of medicine ,RA1-1270 - Abstract
BackgroundRobotic surgery for malignant uterine cancer raises issue of economic sustainability for providers. The objective of this study was to assess the value of surgical admissions for malignant uterine cancer in a University Hospital through an analysis of their costs and outcomes by comparing three different surgical approaches (laparotomy, laparoscopic, and robotic surgery).MethodsHospitalizations between 1 January 2019 and 31 October 2021 for malignant uterine cancer surgery were selected and stratified. For each surgical approach, mean values (with 95% confidence intervals, CI) were calculated for cost items. Moreover, 30-day readmission frequency was calculated for the three approaches compared to each other. ANOVA and Student's t-test and relative risk (RR) were used for statistical analysis. A break-even analysis was carried out by evaluating the volume of robotic and non-robotic surgical admissions.ResultsA total of 1,336 hospitalizations were included in the study, 366 with robotic, 591 with laparoscopic, and 379 with laparotomy surgery. Robotic surgery, compared to laparoscopic and laparotomy ones, showed a statistically significant difference (p < 0.001) in the economic margin, which was largely negative (−1069.18 €; 95%CI:−1240.44-−897.92 €) mainly due to devices cost, and a lower percentage of 30-day readmissions (1.4%; 95%CI: 0.2–2.6%), with a statistically significant difference only vs. laparotomy (p = 0.029). Laparoscopic compared to laparotomy surgery showed a significantly (p < 0,001) more profitable economic margin (1692.21 €; 95%CI: 1531.75 €−1852.66 €) without a significant difference for 30-day readmissions. Break-even analysis showed that, on average, for each malignant uterine cancer elective surgery performed laparoscopically, 1.58 elective robotic surgeries are sustainable for the hospital (95% CI: 1.23–2.06).ConclusionBreak-even analysis could be a useful tool to support hospital management in planning and governance of malignant uterine cancer surgery. Systematic application of this tool will allow defining over time right distribution of robotic, laparoscopic, and laparotomy surgeries' volumes to perform to ensure both quality and economic-financial balance and therefore value of uterine oncological surgery. Concerning research, this study paves the way for a multicentric study, the extension of outcomes of malignant uterine surgery to be considered and assessed, and the future inclusion of other therapeutic interventions in the analysis.
- Published
- 2022
- Full Text
- View/download PDF
22. Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic
- Author
-
Stefania Bruno, Lorenza Nachira, Leonardo Villani, Viria Beccia, Andrea Di Pilla, Domenico Pascucci, Gianluigi Quaranta, Brigida Carducci, Antonietta Spadea, Gianfranco Damiani, Antonio Lanzone, Bruno Federico, and Patrizia Laurenti
- Subjects
pregnancy ,vaccination ,knowledge ,COVID-19 ,vaccine hesitancy ,Public aspects of medicine ,RA1-1270 - Abstract
IntroductionVaccine hesitancy threatens the health of populations and challenges Public Health professionals. Strategies to reduce it aim to improve people's risk perception about vaccine-preventable diseases, fill knowledge gaps about vaccines and increase trust in healthcare providers. During pregnancy, educational interventions can provide a proper knowledge about safety and efficacy of maternal and childhood vaccinations. Fighting hesitancy and clarifying doubts is fundamental during the COVID-19 pandemic, which may have affected people's knowledge and beliefs toward vaccination. This study aimed at assessing if the advent of the pandemic was associated with changes in pregnant women's knowledge and beliefs toward vaccination, and trust in healthcare services.MethodsA repeated cross-sectional study was conducted through self-reported questionnaires in a Roman teaching hospital, where educational classes about vaccinations are routinely held as part of a birthing preparation course. Data were collected on a sample of pregnant women before and during the pandemic. Free-of-charge flu vaccinations were offered to all course participants and adherence to flu vaccination was assessed.ResultsThe proportion of pregnant women reporting that vaccines have mild side effects and that are sufficiently tested increased from 78.6 to 92.0% (p = 0.001) and from 79.4 to 93.2% (p = 0.001), respectively. There was a reduction from 33.0 to 23.3% (p = 0.065) in the proportion of those declaring that healthcare workers (HCWs) give information only on the benefits and not on the risks of vaccines, and a reduction from 27.3 to 12.1% (p = 0.001) in those reporting that vaccines are an imposition and not a free choice of mothers. Trust in National Health Service (NHS) operators slightly decreased. Among participants, the monthly flu vaccination adherence ranged from 50.0% in November to 29.2% January for 2019–20 flu season, and from 56.3% in September to 14.5% in January for 2020–21 flu season, showing a higher vaccination acceptance in the earlier months of 2020-21 flu season.ConclusionsThe pandemic may have positively affected pregnant women's knowledge and opinions about vaccinations and trust in HCWs, despite a possible negative impact on their perceptions about NHS operators. This should inspire Public Health professionals to rethink their role as health communicators.
- Published
- 2022
- Full Text
- View/download PDF
23. Microbial Biocontrol Agents and Natural Products Act as Salt Stress Mitigators in Lactuca sativa L.
- Author
-
Caprari, Claudio, Bucci, Antonio, Ciotola, Anastasia C., Del Grosso, Carmine, Dell'Edera, Ida, Di Bartolomeo, Sabrina, Di Pilla, Danilo, Divino, Fabio, Fortini, Paola, Monaco, Pamela, Palmieri, Davide, Petraroia, Michele, Quaranta, Luca, Lima, Giuseppe, and Ranalli, Giancarlo
- Subjects
EFFECT of salt on plants ,BIOLOGICAL pest control agents ,MICROBIAL products ,BACILLUS amyloliquefaciens ,PLANT communities - Abstract
One of the major problems related to climate change is the increase in land area affected by higher salt concentrations and desertification. Finding economically and environmentally friendly sustainable solutions that effectively mitigate salt stress damage to plants is of great importance. In our work, some natural products and microbial biocontrol agents were evaluated for their long-term effectiveness in reducing salt stress in lettuce (Lactuca sativa L. var. romana) plants. Fourteen different treatments applied to soil pots, with and without salt stress, were analyzed using biometric (leaf and root length and width), physiological (chlorophyll and proline content), and morphological (microscopic preparations) techniques and NGS to study the microbial communities in the soil of plants subjected to different treatments. Under our long-term experimental conditions (90 days), the results showed that salt stress negatively affected plant growth. The statistical analysis showed a high variability in the responses of the different biostimulant treatments. Notably, the biocontrol agents Papiliotrema terrestris (strain PT22AV), Bacillus amyloliquefaciens (strain B07), and Rahnella aquatilis (strain 36) can act as salt stress mitigators in L. sativa. These findings suggest that both microbial biocontrol agents and certain natural products hold promise for reducing the adverse effects of salt stress on plants. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Positive Energy Districts: Fundamentals, Assessment Methodologies, Modeling and Research Gaps.
- Author
-
Kozlowska, Anna, Guarino, Francesco, Volpe, Rosaria, Bisello, Adriano, Gabaldòn, Andrea, Rezaei, Abolfazl, Albert-Seifried, Vicky, Alpagut, Beril, Vandevyvere, Han, Reda, Francesco, Tumminia, Giovanni, Ranjbar, Saeed, Rincione, Roberta, Cellura, Salvatore, Eicker, Ursula, Zamini, Shokufeh, Balsategui, Sergio Diaz de Garayo, Haase, Matthias, and Di Pilla, Lorenza
- Subjects
EVIDENCE gaps ,SOCIAL innovation ,SUSTAINABLE urban development ,FACTORING (Finance) ,SOCIOCULTURAL factors - Abstract
The definition, characterization and implementation of Positive Energy Districts is crucial in the path towards urban decarbonization and energy transition. However, several issues still must be addressed: the need for a clear and comprehensive definition, and the settlement of a consistent design approach for Positive Energy Districts. As emerged throughout the workshop held during the fourth edition of Smart and Sustainable Planning for Cities and Regions Conference (SSPCR 2022) in Bolzano (Italy), further critical points are also linked to the planning, modeling and assessment steps, besides sustainability aspects and stakeholders' involvement. The "World Café" methodology adopted during the workshop allowed for simple—but also effective and flexible—group discussions focused on the detection of key PED characteristics, such as morphologic, socio-economic, demographic, technological, quality-of-life and feasibility factors. Four main work groups were defined in order to allow them to share, compare and discuss around five main PED-related topics: energy efficiency, energy flexibility, e-mobility, soft mobility, and low-carbon generation. Indeed, to properly deal with PED challenges and crucial aspects, it is necessary to combine and balance these technologies with enabler factors like financing instruments, social innovation and involvement, innovative governance and far-sighted policies. This paper proposes, in a structured form, the main outcomes of the co-creation approach developed during the workshop. The importance of implementing a holistic approach was highlighted: it requires a systematic and consistent integration of economic, environmental and social aspects directly connected to an interdisciplinary cross-sectorial collaboration between researchers, policymakers, industries, municipalities, and citizens. Furthermore, it was reaffirmed that, to make informed and reasoned decisions throughout an effective PED design and planning process, social, ecological, and cultural factors (besides merely technical aspects) play a crucial role. Thanks to the valuable insights and recommendations gathered from the workshop participants, a conscious awareness of key issues in PED design and implementation emerged, and the fundamental role of stakeholders in the PED development path was confirmed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Listening to what the system tells us: Innovative auditing for distributed systems.
- Author
-
Piergiuseppe Di Pilla, Remo Pareschi, Francesco Salzano, and Federico Zappone
- Published
- 2022
- Full Text
- View/download PDF
26. Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
- Author
-
Giardina, Emiliano, primary, Mandich, Paola, additional, Ghidoni, Roberta, additional, Ticozzi, Nicola, additional, Rossi, Giacomina, additional, Fenoglio, Chiara, additional, Tiziano, Francesco Danilo, additional, Esposito, Federica, additional, Capellari, Sabina, additional, Nacmias, Benedetta, additional, Mineri, Rossana, additional, Campopiano, Rosa, additional, Di Pilla, Luana, additional, Sammarone, Federica, additional, Zampatti, Stefania, additional, Peconi, Cristina, additional, De Angelis, Flavio, additional, Palmieri, Ilaria, additional, Galandra, Caterina, additional, Nicodemo, Eleonora, additional, Origone, Paola, additional, Gotta, Fabio, additional, Ponti, Clarissa, additional, Nicsanu, Roland, additional, Benussi, Luisa, additional, Peverelli, Silvia, additional, Ratti, Antonia, additional, Ricci, Martina, additional, Di Fede, Giuseppe, additional, Magri, Stefania, additional, Serpente, Maria, additional, Lattante, Serena, additional, Domi, Teuta, additional, Carrera, Paola, additional, Saltimbanco, Elisa, additional, Bagnoli, Silvia, additional, Ingannato, Assunta, additional, Albanese, Alberto, additional, Tagliavini, Fabrizio, additional, Lodi, Raffaele, additional, Caltagirone, Carlo, additional, Gambardella, Stefano, additional, Valente, Enza Maria, additional, and Silani, Vincenzo, additional
- Published
- 2024
- Full Text
- View/download PDF
27. Liposarcoma of the spermatic cord: The state of art and our experience
- Author
-
Di Pilla, Maria Antonietta, primary, Capuano, Marco Alex, additional, Rossi, Mariangela, additional, Di Pilla, Gianni, additional, Minelli, Rocco, additional, Pizzicato, Paolo, additional, Rossi, Antonio, additional, Paviglianiti, Giuseppe, additional, Irace, Donatella, additional, Vallone, Gianfranco, additional, Salvia, Antonio A.H., additional, Smaldone, Maria Cristina, additional, Cariello, Valentina, additional, Zeccolini, Raffaele, additional, and Rossi, Eugenio, additional
- Published
- 2023
- Full Text
- View/download PDF
28. Assessing hospital performance indicators. What dimensions? Evidence from an umbrella review
- Author
-
Elettra Carini, Irene Gabutti, Emanuela Maria Frisicale, Andrea Di Pilla, Angelo Maria Pezzullo, Chiara de Waure, Americo Cicchetti, Stefania Boccia, and Maria Lucia Specchia
- Subjects
Hospital performance ,Performance dimensions ,Performance measurement ,Hospital evaluation ,Quality ,Indicator ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Patients’ increasing needs and expectations require an overall assessment of hospital performance. Several international agencies have defined performance indicators sets but there exists no unanimous classification. The Impact HTA Horizon2020 Project wants to address this aspect, developing a toolkit of key indicators to measure hospital performance. The aim of this review is to identify and classify the dimensions of hospital performance indicators in order to develop a common language and identify a shared evidence-based way to frame and address performance assessment. Methods Following the PRISMA statement, PubMed, Cochrane Library and Web of Science databases were queried to perform an umbrella review. Reviews focusing on hospital settings, published January 2000–June 2019 were considered. The quality of the studies selected was assessed using the AMSTAR2 tool. Results Six reviews ranging 2002–2014 were included. The following dimensions were described in at least half of the studies: 6 studies classified efficiency (55 indicators analyzed); 5 studies classified effectiveness (13 indicators), patient centeredness (10 indicators) and safety (8 indicators); 3 studies responsive governance (2 indicators), staff orientation (10 indicators) and timeliness (4 indicators). Three reviews did not specify the indicators related to the dimensions listed, and one article gave a complete definition of the meaning of each dimension and of the related indicators. Conclusions The research shows emphasis of the importance of patient centeredness, effectiveness, efficiency, and safety dimensions. Especially, greater attention is given to the dimensions of effectiveness and efficiency. Assessing the overall quality of clinical pathways is key in guaranteeing a truly effective and efficient system but, to date, there still exists a lack of awareness and proactivity in terms of measuring performance of nodes within networks. The effort of classifying and systematizing performance measurement techniques across hospitals is essential at the organizational, regional/national and possibly international levels to deliver top quality care to patients.
- Published
- 2020
- Full Text
- View/download PDF
29. COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
- Author
-
Luciana Caravatta, Consuelo Rosa, Maria Bernadette Di Sciascio, Andrea Tavella Scaringi, Angelo Di Pilla, Lucia Anna Ursini, Maria Taraborrelli, Annamaria Vinciguerra, Antonietta Augurio, Monica Di Tommaso, Marianna Trignani, Marianna Nuzzo, Maria Daniela Falco, Andrea De Nicola, Nico Adorante, Fabiola Patani, Giuseppe Centofanti, Lucrezia Gasparini, David Fasciolo, Fiorella Cristina Di Guglielmo, Cecilia Bonfiglio, Marzia Borgia, Gabriella Caravaggio, Stefano Marcucci, Consalvo Turchi, Domenico Mancinelli, Stephanie Sartori, Thomas Schael, Angelo Muraglia, Sergio Caputi, Claudio D’Amario, Nicoletta Verì, and Domenico Genovesi
- Subjects
Coronavirus ,COVID-19 ,Pandemic ,Radiation oncology ,Radiotherapy ,SARS-CoV-2 ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background COVID-19 in Italy has led to the need to reorganize hospital protocols with a significant risk of interruption to cancer treatment programs. In this report, we will focus on a management model covering the two phases of the COVID-19 emergency, namely lockdown-phase I and post-lockdown-phase II. Methods The following steps were taken in the two phases: workload during visits and radiotherapy planning, use of dedicated routes, measures for triage areas, management of suspected and positive COVID-19 cases, personal protective equipment, hospital environments and intra-institutional meetings and tumor board management. Due to the guidelines set out by the Ministry of Health, oncological follow-up visits were interrupted during the lockdown-phase I; consequently, we set about contacting patients by telephone, with laboratory and instrumental exams being viewed via telematics. During the post-lockdown-phase II, the oncological follow-up clinic reopened, with two shifts operating daily. Results By comparing our radiotherapy activity from March 9 to May 4 2019 with the same period in 2020 during full phase I of the COVID-19 emergency, similar results were achieved. First radiotherapy visits, Simulation Computed Tomography and Linear Accelerator treatments amounted to 123, 137 and 151 in 2019 compared with 121, 135 and 170 in 2020 respectively. There were no cases of COVID-19 positivity recorded either in patients or in healthcare professionals, who were all negative to the swab tests performed. Conclusion During both phases of the COVID-19 emergency, the planned model used in our own experience guaranteed both continuity in radiotherapy treatments whilst neither reducing workload nor interrupting treatment and, as such, it ensured the safety of cancer patients, hospital environments and staff.
- Published
- 2020
- Full Text
- View/download PDF
30. The impact of tumor board on cancer care: evidence from an umbrella review
- Author
-
Maria Lucia Specchia, Emanuela Maria Frisicale, Elettra Carini, Andrea Di Pilla, Danila Cappa, Andrea Barbara, Walter Ricciardi, and Gianfranco Damiani
- Subjects
Healthcare ,Tumor board ,Multidisciplinary team ,Diagnostic accuracy ,Personalized treatment ,Personalized medical care ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Tumor Boards (TBs) are Multidisciplinary Team (MDT) meetings in which different specialists work together closely sharing clinical decisions in cancer care. The composition is variable, depending on the type of tumor discussed. As an organizational tool, MDTs are thought to optimize patient outcomes and to improve care performance. The aim of the study was to perform an umbrella review summarizing the available evidence on the impact of TBs on healthcare outcomes and processes. Methods Pubmed and Web of Science databases were investigated along with a search through citations. The only study design included was systematic review. Only reviews published after 1997 concerning TBs and performed in hospital settings were considered. Two researchers synthetized the studies and assessed their quality through the AMSTAR2 tool. Results Five systematic reviews published between 2008 and 2017 were retrieved. One review was focused on gastrointestinal cancers and included 16 studies; another one was centered on lung cancer and included 16 studies; the remaining three studies considered a wide range of tumors and included 27, 37 and 51 studies each. The main characteristics about format and members and the definition of TBs were collected. The decisions taken during TBs led to changes in diagnosis (probability to receive a more accurate assessment and staging), treatment (usually more appropriate) and survival (not unanimous improvement shown). Other outcomes less highlighted were quality of life, satisfaction and waiting times. Conclusions The study showed that the multidisciplinary approach is the best way to deliver the complex care needed by cancer patients; however, it is a challenge that requires organizational and cultural changes and must be led by competent health managers who can improve teamwork within their organizations. Further studies are needed to reinforce existing literature concerning health outcomes. Evidence on the impact of TBs on clinical practices is still lacking for many aspects of cancer care. Further studies should aim to evaluate the impact on survival rates, quality of life and patient satisfaction. Regular studies should be carried out and new process indicators should be defined to assess the impact and the performance of TBs more consistently.
- Published
- 2020
- Full Text
- View/download PDF
31. Indicatori epidemiologici
- Author
-
Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, Specchia, Maria Lucia, andrea di pilla, gianfranco damiani (ORCID:0000-0003-3028-6188), maria lucia specchia (ORCID:0000-0002-3859-4591), Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, Specchia, Maria Lucia, andrea di pilla, gianfranco damiani (ORCID:0000-0003-3028-6188), and maria lucia specchia (ORCID:0000-0002-3859-4591)
- Abstract
Osservando i valori di mortalità nelle diverse ondate nelle Regio- ni italiane, si può notare come le prime ondate siano state quelle più drammatiche per il numero di deceduti con diagnosi di Covid-19: in particolare, la prima ondata ha fatto registrare valori di mortalità par- ticolarmente alti in tutto il gruppo delle Regioni del Nord maggior- mente colpite dall’epidemia. In seguito, pur essendo aumentato con- sistentemente il numero di casi a livello nazionale, la mortalità è ri- masta relativamente contenuta: questo è particolarmente evidente per la quarta ondata, che pur registrando i massimi valori di incidenza in tutte le Regioni, non vede valori di mortalità conseguentemente alti.
- Published
- 2023
32. Indicatori di monitoraggio del contagio
- Author
-
Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, Specchia, Maria Lucia, andrea di pilla, gianfranco damiani (ORCID:0000-0003-3028-6188), lucia specchia (ORCID:0000-0002-3859-4591), Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, Specchia, Maria Lucia, andrea di pilla, gianfranco damiani (ORCID:0000-0003-3028-6188), and lucia specchia (ORCID:0000-0002-3859-4591)
- Abstract
Nell’ambito del presente capitolo vengono mostrati gli indica- tori di monitoraggio e contagio. I primi casi di infezione di SARS- CoV-2 in Italia sono stati individuati a fine febbraio 2020 nei co- muni di Codogno (Lombardia) e Vo Euganeo (Veneto). Il 9 mar- zo, l’intero territorio italiano è stato sottoposto alla misura del lockdown per limitare la diffusione dell’epidemia, che due giorni dopo veniva dichiarata pandemica dalla World Health Organiza- tion. I principali indicatori presi in considerazione per monitorare l’andamento dei contagi sono stati l’incidenza e la prevalenza dei casi estratti grazie ai dati pubblicati quotidianamente dalla Prote- zione Civile. Per riepilogare gli andamenti generali dei valori re- gistrati – che hanno subito delle fisiologiche oscillazioni legate essenzialmente al flusso dei dati – il calcolo è stato raffinato tra- mite una media mobile.
- Published
- 2023
33. Campagna vaccinale anti COVID-19
- Author
-
Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, di brino, Eugenio, andrea di pilla, gianfranco damiani (ORCID:0000-0003-3028-6188), Americo Cicchetti e Eugenio Di Brino, Di Pilla, Andrea, Damiani, Gianfranco, di brino, Eugenio, andrea di pilla, and gianfranco damiani (ORCID:0000-0003-3028-6188)
- Abstract
Il 27 dicembre 2020 è iniziata in Italia la campagna vaccinale anti-Covid-19; con una latenza di circa 20 giorni (dovuta alla pro- grammazione del ciclo vaccinale) inizia anche la somministrazio- ne delle seconde dosi, che segue a distanza l’andamento della somministrazione delle prime dosi. Dopo un periodo di stallo alla fine di gennaio, la somministrazione giornaliera dei vaccini cresce fino all’estate del 2021, arrivando a dei picchi nei mesi di giugno e luglio 2021 e aggiungendo poi a settembre la somministrazione delle terze dosi.
- Published
- 2023
34. Stroke pathway performance assessment: a retrospective observational study
- Author
-
Camporesi, J, Strumia, S, Di Pilla, Andrea, Paolucci, M, Orsini, Diego, Assorgi, C, Cacciuttolo, Maria Gabriella, Specchia, Maria Lucia, Di Pilla A, Orsini D, Cacciuttolo MG, Specchia ML (ORCID:0000-0002-3859-4591), Camporesi, J, Strumia, S, Di Pilla, Andrea, Paolucci, M, Orsini, Diego, Assorgi, C, Cacciuttolo, Maria Gabriella, Specchia, Maria Lucia, Di Pilla A, Orsini D, Cacciuttolo MG, and Specchia ML (ORCID:0000-0002-3859-4591)
- Abstract
Background and Aim: Performance assessment of the Stroke Pathway is a key element in healthcare quality. The aim of this study has been to carry out a retrospective assessment of the Stroke Pathway in a first level Stroke Unit in Italy, analyzing the temporal trend of the Stroke Pathway performance and the impact of the COVID-19 pandemic. Methods: A retrospective observational study was carried out analyzing data from 1/01/2010 to 31/12/2020. The following parameters were considered: volume and characteristics of patients with ischemic stroke undergoing intravenous thrombolysis, baseline modified Rankin Scale (mRS) and National Institutes of Health Stroke Scale (NIHSS) scores, Onset-to-Door (OTD), Door-To-Imaging (DTI) and Door-To-Needle (DTN) Times, mRS score 3 months after the ischemic event onset (3 m-mRS) and NIHSS score 24 h after the ischemic event onset (24 h-NIHSS). The study also compared the pre-COVID-19 pandemic period (March-December 2019) with the one immediately following it (March-December 2020). Results: 418 patients were included. Over time, treatment was extended to older patients (mean age from 66.3 to 75.51 years; p = 0.006) and with a higher level of baseline disability (baseline mRS score from 0.22 to 1.22; p = 0.000). A statistically significant reduction over the years was found for DTN, going from 90 min to 61 min (p = 0.000) with also an increase in the number of thrombolysis performed within the “golden hour” – more than 50% in 2019 and more of 60% in 2020. Comparing pre- and during COVID-19 pandemic periods, the number of patients remained almost unchanged, but with a significantly higher baseline disability (mRS = 1.18 vs. 0.72, p = 0.048). The pre-hospital process indicator OTD increased from 88.13 to 118.48 min, although without a statistically significant difference (p = 0.197). Despite the difficulties for hospitals due to pandemic, the hospital process indicators DTI and DTN remained substantially unchanged, as well as the clinical
- Published
- 2023
35. An online survey among general pediatricians on melatonin use in children with chronic insomnia
- Author
-
Bruni, Oliviero, primary, Breda, Maria, additional, Malorgio, Emanuela, additional, Brambilla, Paolo, additional, Ceschin, Flavia, additional, Di Pilla, Andrea, additional, Elia, Maurizio, additional, and Ferri, Raffaele, additional
- Published
- 2023
- Full Text
- View/download PDF
36. Stroke Pathway impact on healthcare processes and outcomes: a retrospective observational study
- Author
-
Di Pilla, A, primary, Camporesi, J, additional, Strumia, S, additional, Paolucci, M, additional, Cacciuttolo, M G, additional, Orsini, D, additional, Assorgi, C, additional, and Specchia, M L, additional
- Published
- 2023
- Full Text
- View/download PDF
37. Building Wall Heat Capacity Measurement Through Flux Sensors
- Author
-
Roberto Ricciu, Alessandra Galatioto, Luigi A. Besalduch, Giuseppe Desogus, and Lorenza Di Pilla
- Subjects
Lightweight walls ,Specific heat capacity ,Climatic chamber ,Experimental tests ,Physical propriety ,Dynamic model ,Energy saving. ,Technology ,Economic growth, development, planning ,HD72-88 - Abstract
Thermal comfort and energy saving have become a priority for construction industry professionals. An important parameter of the comfort is the mean radiant temperature and its dependence on the building envelope. In the present research, a dynamic physical model has been studied in a climatic chamber, linked to the specific heat (C), density (r) and thermal conductivity (l). The heat capacity is usually quantifiable in small, homogeneous and uniform samples by the application of calorimetric methods. Consequently, the building energy consumption assessed through calorimetric methods, is often quite different from the energy consumption measured in situ. In this work an experimental model for the assessment of specific heat of real-size building components is proposed. Such a parameter was determined by measuring the heat flow through a building wall. The model has been validated by comparing the evaluated properties of known materials for different thermal gaps.
- Published
- 2019
- Full Text
- View/download PDF
38. Sleep habits and sleep disorders in Italian children and adolescents: a cross-sectional survey
- Author
-
Maria Breda, Arianna Belli, Dario Esposito, Andrea Di Pilla, Maria Grazia Melegari, Lourdes DelRosso, Emanuela Malorgio, Mattia Doria, Raffaele Ferri, and Oliviero Bruni
- Subjects
Pulmonary and Respiratory Medicine ,Neurology ,Neurology (clinical) - Published
- 2023
- Full Text
- View/download PDF
39. Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital
- Author
-
Domenico Pascucci, Mario Cesare Nurchis, Alberto Lontano, Eleonora Marziali, Giuseppe Vetrugno, Andrea Cambieri, Umberto Moscato, Andrea Di Pilla, Gianfranco Damiani, and Patrizia Laurenti
- Subjects
flu vaccination ,COVID-19 ,healthcare workers ,vaccination coverage ,public health ,Medicine - Abstract
Influenza represents a threat to global health and health care workers (HCWs) have an increased risk of contracting the influenza virus in the workplace. The COVID-19 pandemic has brought back the importance of influenza vaccination, as the influenza virus can circulate together with SARS-CoV-2. The aim of this report is to describe the actual flu vaccination coverage among healthcare workers of a research hospital and the trend changes, with respect to the past flu vaccination campaigns, in light of the present pandemic and COVID-19 vaccination. A Pearson’s χ2 test was used to test the correlation of flu vaccination coverage, across all professional categories, between the last two years. A linear regression model was adopted to predict the total vaccination coverage of this year. A statistically significant decrease (p < 0.01) was observed in vaccination coverage among all the professional categories with a 50% reduction in vaccination trends between the last two years. Analyzing the data from the previous six flu vaccination campaigns, the expected value, according to the linear regression model, was estimated to be 38.5% while the observed value was 24%. The decrease in vaccination coverage may be due to the fear of the pandemic situation and especially to the uncertainty related to the consequences of a concurrent administration which may overload the immune system or may be more reactogenic. The COVID-19 pandemic represents an opportunity to promote and support large-scale influenza vaccination among HCWs through structured programs, adequate funding, and tailored communication strategies.
- Published
- 2022
- Full Text
- View/download PDF
40. An Adaptive Neural Network model for thermal characterization of building components
- Author
-
Baccoli, R., Di Pilla, L., Frattolillo, A., and Mastino, C.C.
- Published
- 2017
- Full Text
- View/download PDF
41. Assessing hospital performance indicators. What dimensions? Evidence from an umbrella review
- Author
-
Carini, Elettra, Gabutti, Irene, Frisicale, Emanuela Maria, Di Pilla, Andrea, Pezzullo, Angelo Maria, de Waure, Chiara, Cicchetti, Americo, Boccia, Stefania, and Specchia, Maria Lucia
- Published
- 2020
- Full Text
- View/download PDF
42. COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy
- Author
-
Caravatta, Luciana, Rosa, Consuelo, Di Sciascio, Maria Bernadette, Tavella Scaringi, Andrea, Di Pilla, Angelo, Ursini, Lucia Anna, Taraborrelli, Maria, Vinciguerra, Annamaria, Augurio, Antonietta, Di Tommaso, Monica, Trignani, Marianna, Nuzzo, Marianna, Falco, Maria Daniela, De Nicola, Andrea, Adorante, Nico, Patani, Fabiola, Centofanti, Giuseppe, Gasparini, Lucrezia, Fasciolo, David, Di Guglielmo, Fiorella Cristina, Bonfiglio, Cecilia, Borgia, Marzia, Caravaggio, Gabriella, Marcucci, Stefano, Turchi, Consalvo, Mancinelli, Domenico, Sartori, Stephanie, Schael, Thomas, Muraglia, Angelo, Caputi, Sergio, D’Amario, Claudio, Verì, Nicoletta, and Genovesi, Domenico
- Published
- 2020
- Full Text
- View/download PDF
43. The impact of tumor board on cancer care: evidence from an umbrella review
- Author
-
Specchia, Maria Lucia, Frisicale, Emanuela Maria, Carini, Elettra, Di Pilla, Andrea, Cappa, Danila, Barbara, Andrea, Ricciardi, Walter, and Damiani, Gianfranco
- Published
- 2020
- Full Text
- View/download PDF
44. Radiological response criteria in non-small cell lung cancer treated with immunotherapy: RECIST1.1 vs. iRECIST
- Author
-
EVANGELISTA, Antonio P., primary, DI PILLA, Maria A., additional, MINELLI, Rocco, additional, CAPUANO, Marco A., additional, ROSSI, Mariangela, additional, TRAFICANTE, Divina, additional, VALLONE, Gianfranco, additional, and DI PILLA, Gianni, additional
- Published
- 2023
- Full Text
- View/download PDF
45. Radiological response criteria in non-small cell lung cancer treated with immunotherapy: RECIST1.1 vs. iRECIST
- Author
-
Antonio P. EVANGELISTA, Maria A. DI PILLA, Rocco MINELLI, Marco A. CAPUANO, Mariangela ROSSI, Divina TRAFICANTE, Gianfranco VALLONE, and Gianni DI PILLA
- Published
- 2023
- Full Text
- View/download PDF
46. A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis
- Author
-
Specchia, Maria Lucia, Di Pilla, Andrea, Gambacorta, Maria Antonietta, Filippella, Alessandro, Beccia, Flavia, Farina, Sara, Meldolesi, Elisa, Lanza, Chiara, Bellantone, Rocco Domenico Alfonso, Valentini, Vincenzo, Tortora, Giampaolo, Maria Lucia Specchia (ORCID:0000-0002-3859-4591), Andrea Di Pilla, Maria Antonietta Gambacorta (ORCID:0000-0001-5455-8737), Flavia Beccia, Sara Farina, Elisa Meldolesi, Rocco Bellantone (ORCID:0000-0002-0844-3469), Vincenzo Valentini (ORCID:0000-0003-4637-6487), Giampaolo Tortora (ORCID:0000-0002-1378-4962), Specchia, Maria Lucia, Di Pilla, Andrea, Gambacorta, Maria Antonietta, Filippella, Alessandro, Beccia, Flavia, Farina, Sara, Meldolesi, Elisa, Lanza, Chiara, Bellantone, Rocco Domenico Alfonso, Valentini, Vincenzo, Tortora, Giampaolo, Maria Lucia Specchia (ORCID:0000-0002-3859-4591), Andrea Di Pilla, Maria Antonietta Gambacorta (ORCID:0000-0001-5455-8737), Flavia Beccia, Sara Farina, Elisa Meldolesi, Rocco Bellantone (ORCID:0000-0002-0844-3469), Vincenzo Valentini (ORCID:0000-0003-4637-6487), and Giampaolo Tortora (ORCID:0000-0002-1378-4962)
- Abstract
Background and Objective: Colorectal cancer (RC) is the third most common cancer, with an increasing incidence in recent years but also significant improvements in clinical outcomes. Modern treatment strategies are based on the close working of related disciplines within Multidisciplinary Tumour Boards (MTBs). This study has been aimed to implement a digital solution within the RC-MTB and analyse its impact in the context of the Fondazione Policlinico ‘A. Gemelli’ in Italy. Methods: A multidisciplinary working group was created for the platform customization according to the RC-MTB specific needs (definition of the data to be recorded and stored in the platform for each clinical case discussed) and its integration into the hospital IT system to allow the automatic import of patients’ data. Subsequently, the platform was validated through a pilot test and operatively launched. The platform impact analysis was carried out through a pre-post comparison of the RC-MTB. Descriptive and inferential analyses were performed, with a p-value < 0.05 being considered statistically significant. Results: The implementation of the platform allowed more healthcare professionals
- Published
- 2022
47. An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis
- Author
-
Specchia, Maria Lucia, Di Pilla, Andrea, Gambacorta, Maria Antonietta, Filippella, A, Beccia, Flavia, Farina, Sara, Meldolesi, Elisa, Lanza, C, Bellantone, Rocco Domenico Alfonso, Valentini, Vincenzo, Tortora, Giampaolo, Specchia ML (ORCID:0000-0002-3859-4591), Di Pilla A, Gambacorta MA (ORCID:0000-0001-5455-8737), Beccia F, Farina S, Meldolesi E, Bellantone RDA (ORCID:0000-0002-0844-3469), Valentini V (ORCID:0000-0003-4637-6487), Tortora G (ORCID:0000-0002-1378-4962), Specchia, Maria Lucia, Di Pilla, Andrea, Gambacorta, Maria Antonietta, Filippella, A, Beccia, Flavia, Farina, Sara, Meldolesi, Elisa, Lanza, C, Bellantone, Rocco Domenico Alfonso, Valentini, Vincenzo, Tortora, Giampaolo, Specchia ML (ORCID:0000-0002-3859-4591), Di Pilla A, Gambacorta MA (ORCID:0000-0001-5455-8737), Beccia F, Farina S, Meldolesi E, Bellantone RDA (ORCID:0000-0002-0844-3469), Valentini V (ORCID:0000-0003-4637-6487), and Tortora G (ORCID:0000-0002-1378-4962)
- Abstract
Colorectal cancer (RC) is the third most common cancer, with an increasing incidence in recent years. Digital health solutions supporting multidisciplinary tumor boards (MTBs) could improve positive outcomes for RC patients. This paper describes the implementation process of a digital solution within the RC-MTB and its impact analysis in the context of the Fondazione Policlinico 'A. Gemelli' in Italy. Adopting a two-phase methodological approach, the first phase qualitatively describes each phase of the implementation of the IT platform, while the second phase quantitatively describes the analysis of the impact of the IT platform. Descriptive and inferential analyses were performed for all variables, with a p-value < 0.05 being considered statistically significant. The implementation of the platform allowed more healthcare professionals to attend meetings and resulted in a decrease in patients sent to the RC-MTB for re-staging and further diagnostic investigations and an increase in patients sent to the RC-MTB for treatment strategies. The results could be attributed to the facilitated access to the platform remotely for specialists, partly compensating for the restrictions imposed by the COVID-19 pandemic, as well as to the integration of the platform into the hospital's IT system. Furthermore, the early involvement of healthcare professionals in the process of customizing the platform to the specific needs of the RC-MTB may have facilitated its use and contributed to the encouraging quantitative results
- Published
- 2022
48. The value of surgical admissions for malignant uterine cancer. A comparative analysis of robotic, laparoscopic, and laparotomy surgery in a university hospital
- Author
-
Specchia, Maria Lucia, Arcuri, Giovanni, Di Pilla, Andrea, La Gatta, Emanuele, Osti, Tommaso, Limongelli, P, Scambia, Giovanni, Bellantone, Rocco Domenico Alfonso, Specchia ML (ORCID:0000-0002-3859-4591), Arcuri G, Di Pilla A, La Gatta E, Osti T, Scambia G (ORCID:0000-0003-2758-1063), Bellantone RDA (ORCID:0000-0002-0844-3469), Specchia, Maria Lucia, Arcuri, Giovanni, Di Pilla, Andrea, La Gatta, Emanuele, Osti, Tommaso, Limongelli, P, Scambia, Giovanni, Bellantone, Rocco Domenico Alfonso, Specchia ML (ORCID:0000-0002-3859-4591), Arcuri G, Di Pilla A, La Gatta E, Osti T, Scambia G (ORCID:0000-0003-2758-1063), and Bellantone RDA (ORCID:0000-0002-0844-3469)
- Abstract
Background: Robotic surgery for malignant uterine cancer raises issue of economic sustainability for providers. The objective of this study was to assess the value of surgical admissions for malignant uterine cancer in a University Hospital through an analysis of their costs and outcomes by comparing three different surgical approaches (laparotomy, laparoscopic, and robotic surgery). Methods: Hospitalizations between 1 January 2019 and 31 October 2021 for malignant uterine cancer surgery were selected and stratified. For each surgical approach, mean values (with 95% confidence intervals, CI) were calculated for cost items. Moreover, 30-day readmission frequency was calculated for the three approaches compared to each other. ANOVA and Student's t-test and relative risk (RR) were used for statistical analysis. A break-even analysis was carried out by evaluating the volume of robotic and non-robotic surgical admissions. Results: A total of 1,336 hospitalizations were included in the study, 366 with robotic, 591 with laparoscopic, and 379 with laparotomy surgery. Robotic surgery, compared to laparoscopic and laparotomy ones, showed a statistically significant difference (p < 0.001) in the economic margin, which was largely negative (-1069.18 €; 95%CI:-1240.44--897.92 €) mainly due to devices cost, and a lower percentage of 30-day readmissions (1.4%; 95%CI: 0.2-2.6%), with a statistically significant difference only vs. laparotomy (p = 0.029). Laparoscopic compared to laparotomy surgery showed a significantly (p < 0,001) more profitable economic margin (1692.21 €; 95%CI: 1531.75 €-1852.66 €) without a significant difference for 30-day readmissions. Break-even analysis showed that, on average, for each malignant uterine cancer elective surgery performed laparoscopically, 1.58 elective robotic surgeries are sustainable for the hospital (95% CI: 1.23-2.06). Conclusion: Break-even analysis could be a useful tool to support hospital management in planning and governance
- Published
- 2022
49. Narrative Review of the COVID-19 Pandemic’s First Two Years in Italy
- Author
-
Flavia Beccia, Andrea Di Pilla, Francesco Andrea Causio, Bruno Federico, Maria Lucia Specchia, Carlo Favaretti, Stefania Boccia, Gianfranco Damiani, Beccia, Flavia, Di Pilla, Andrea, Causio, Francesco Andrea, Federico, Bruno, Specchia, Maria Lucia (ORCID:0000-0002-3859-4591), Favaretti, Carlo, Boccia, Stefania (ORCID:0000-0002-1864-749X), Damiani, Gianfranco (ORCID:0000-0003-3028-6188), Flavia Beccia, Andrea Di Pilla, Francesco Andrea Causio, Bruno Federico, Maria Lucia Specchia, Carlo Favaretti, Stefania Boccia, Gianfranco Damiani, Beccia, Flavia, Di Pilla, Andrea, Causio, Francesco Andrea, Federico, Bruno, Specchia, Maria Lucia (ORCID:0000-0002-3859-4591), Favaretti, Carlo, Boccia, Stefania (ORCID:0000-0002-1864-749X), and Damiani, Gianfranco (ORCID:0000-0003-3028-6188)
- Abstract
Italy was the first country in the western world to be affected by the COVID-19 pandemic, arguably among the worst-affected ones, counting 12 million cases and 150 thousand deaths two years since the first case. Facing new challenges, Italy has enacted different strategies and policies to limit the spread of the SARS-CoV-2 virus and treat those affected by COVID-19. This narrative review provided an overview of factors, measures, and actions that shaped Italy’s first two years of the COVID-19 pandemic by investigating epidemiological data and using a mixed-method approach. This narrative review aimed to summarize the most relevant aspects and measures and analyze available data to provide policymakers and healthcare providers with the instruments to learn from this pandemic and improve their preparedness for future pandemic events. The first two years of the pandemic differ in that, during the first year, significant necessary changes to the way health systems were organized were implemented, increasing healthcare spending and adopting social and physical distancing measures that were stricter than the ones adopted in the second year. However, as the pandemic progressed, increased knowledge of the virus and related variants, as well as the introduction of highly effective vaccines, which were not equally available to the whole population, resulted in a stratification of COVID-19 infections and deaths based on factors such as age, vaccination status, and individual susceptibility to the virus.
- Published
- 2022
50. Insights on DRGs, guideline compliance and economic sustainability. The case of mastectomy with immediate breast reconstruction
- Author
-
Specchia, Maria Lucia, Arcuri, Giovanni, Di Pilla, Andrea, Limongelli, Paola Enrica, Salgarello, Marzia, Masetti, Riccardo, Bellantone, Rocco Domenico Alfonso, Specchia ML (ORCID:0000-0002-3859-4591), Arcuri G, Di Pilla A, Limongelli P (ORCID:0000-0001-7753-9379), Salgarello M (ORCID:0000-0003-4296-4214), Masetti R (ORCID:0000-0002-7520-9111), Bellantone RDA (ORCID:0000-0002-0844-3469), Specchia, Maria Lucia, Arcuri, Giovanni, Di Pilla, Andrea, Limongelli, Paola Enrica, Salgarello, Marzia, Masetti, Riccardo, Bellantone, Rocco Domenico Alfonso, Specchia ML (ORCID:0000-0002-3859-4591), Arcuri G, Di Pilla A, Limongelli P (ORCID:0000-0001-7753-9379), Salgarello M (ORCID:0000-0003-4296-4214), Masetti R (ORCID:0000-0002-7520-9111), and Bellantone RDA (ORCID:0000-0002-0844-3469)
- Abstract
Background. Immediate breast reconstruction is recommended for eligible patients undergoing mastectomy, raising the issue of economic sustainability of both mastectomy and breast reconstruction performed within the same hospitalization, as opposed to two surgical procedures in two different hospitalizations. Study design. A retrospective analysis was conducted to compare economic sustainability of mastectomies with or without immediate breast reconstruction. Methods. Economic data on hospitalizations for mastectomy in a Teaching Hospital between 1 January 2019 and 31 March 2021 were analyzed to assess their sustainability. Results. 338 admissions were selected (63.9% with immediate breast reconstruction (CI 99%: 57.2% to 70.6%). Compared to mastectomy alone, mastectomy with immediate breast reconstruction had higher cost of € 2,245 (p < 0.001), with operating rooms and devices as main cost drivers. Current reimbursements rates (which are the same for mastectomy alone and for mastectomy with immediate breast reconstruction) led to an average loss of € 1,719 for each mastectomy with immediate breast reconstruction. Conclusion. Current DRGs reimbursement rates for hospital admissions for breast cancer surgery do not guarantee immediate breast reconstruction’s economic sustainability. DRGs system should be revised, or other solutions as bundled payment should be implemented in the light of the costs of innovation in healthcare, considering mastectomy and breast reconstruction steps in a path of linked actions aimed at improving patients’ health.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.